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The Role of Neurokinin B in the Regulation of the Preovulatory LH Surge in Ewes 
Katrina L. Porter 
 Hypothalamic input is vital to the regulation of reproductive function. Gonadotropin-releasing 
hormone (GnRH) is secreted by hypothalamic GnRH neurons into the hypophysial portal circulation. 
When GnRH reaches the anterior pituitary, it stimulates gonadotropes to secrete luteinizing hormone 
(LH) into the systemic circulation, ultimately leading to ovulation. GnRH/LH secretion occurs in two 
different patterns: pulsatile or surge. Pulsatile GnRH release is governed by estradiol (E2) negative 
feedback while surge release is the result of E2 positive feedback. However, GnRH neurons lack the alpha 
isoform of the estrogen receptor, indicating that E2 feedback on GnRH release is indirect. Other 
hypothalamic neurons that express ERα have been identified as possible intermediates in this E2 feedback 
pathway, including those containing neurokinin B (NKB) and kisspeptin.  
 Kisspeptin has been identified as a potent stimulator of LH secretion in a variety of species. 
GnRH neurons express the kisspeptin receptor (Kiss1r), indicating that kisspeptin can directly stimulate 
GnRH secretion. Two anatomically separate populations have been identified in the hypothalamus: one in 
the arcuate nucleus (ARC) and the other in the preoptic area (POA). Furthermore, ARC kisspeptin 
neurons have been found to colocalize two other neuropeptides as well: NKB and dynorphin A (DYN). 
Thus, these neurons were assigned the acronym KNDy neurons. The specific role of these two kisspeptin-
containing populations in GnRH/LH regulation is unclear. Therefore we examined the degree to which 
each of these populations were activated, using cFos as an index of activation, during positive E2 
feedback (surge) or following E2 withdraw (i.e. after ovariectomy). We found that both populations 
exhibited increased activation during the GnRH/LH surge, indicating that both are involved in E2-positive 
feedback. Only the ARC kisspeptin neurons showed increased activation after E2 withdrawal, indicating 
that only the KNDy neurons are playing a role in E2-negative feedback control of GnRH release. 
 NKB neurons have been shown to consistently stimulate GnRH/LH secretion in non-rodent 
species. Since KNDy neurons express receptors for NKB (NK3R), the current proposed model suggests 
 
that NKB acts in a paracrine or autocrine fashion to stimulate kisspeptin release from KNDy neurons 
which then acts directly to initiate a pulse of GnRH.  Dynorphin from KNDy neurons then acts to 
terminate kisspeptin release and end the pulse of GnRH release.  However, high levels of neurokinin-3-
receptor (NK3R) are found outside of KNDy neurons in the ovine POA, ARC, retrochiasmatic area 
(RCh), and paraventricular nucleus (PVN). We first examined whether NKB or senktide, an NK3R 
agonist, would alter LH secretion if placed within each of these areas. While NKB, in any of those areas, 
had no effect on LH secretion, senktide placed in either the RCh or POA stimulated a surge-like secretion 
of LH, suggesting that NK3R activation in these areas may play a role in the GnRH/LH surge. Thus, we 
subsequently placed an NK3R antagonist in the RCh or POA during an E2-induced LH surge and found 
that blocking NK3R in the RCh, but not the POA, significantly suppressed LH surge amplitude. These 
results suggest that NK3R activation in the RCh is essential for the full LH surge.  
 As mentioned above, one current model suggests that NKB exerts its actions via kisspeptin output 
to GnRH neurons; however, this has not been examined in ewes. We first assessed activation of the ARC 
and POA populations of kisspeptin neurons following senktide treatment in either the RCh or POA. We 
found that senktide in either area significantly increased ARC kisspeptin neuron activation but did not 
alter activity of POA kisspeptin neurons. To further test the model, we gave a Kiss1r-antagonist (via 
intracerebroventricular infusion) during senktide treatment to see if blocking kisspeptin receptors would 
ameliorate senktide-induced surge-like LH secretion. This experiment yielded inconsistent results, with 
the increase in LH blocked in some ewes by Kiss1r antagonist infusion but not in others.  Nonetheless, 
based on the activation data, we conclude that NK3R activation stimulates LH secretion via ARC 
kisspeptin neurons.  
 In conclusion, we have identified a role for NK3R-positive neurons in the RCh in regulating the 
LH surge in ewes. These data reveal the importance of the RCh in the LH surge, an area whose 
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THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS 
 The estrous cycle is regulated by a complex feedback loop composed of hypothalamic neurons, 
the pituitary, and gonads. These components are collectively known as the hypothalamic-pituitary-
gonadal axis. As there are some differences across species, I will discuss these differences throughout this 
literature review. Neurons containing gonadotropin-releasing hormone (GnRH) in the ewe are found 
throughout the preoptic area (POA) and mediobasal hypothalamus (MBH), with nearly half of them 
terminating in the median eminence (ME) (1;2). When stimulated, these neurons synthesize and then 
secrete GnRH into the fenestrated capillaries of the hypophyseal portal system at the ME. GnRH, as its 
name implies, stimulates gonadotropes in the anterior pituitary to synthesize and secrete the two 
gonadotropins (so-named due to their role in stimulating the gonads), luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH), into the systemic circulation.  
1. The Reproductive Cycle in Ewes and Primates 
 The estrous cycle in ewes (3) and the menstrual cycle in primates (4) average 16-17 days and 28 
days, respectively, in length and consists of two phases, follicular and luteal, which are named for the 
dominating ovarian structure during that period. Compared to primates, the relatively shorter estrous 
cycle in ewes is due to a shortened follicular phase. Depending on the phase of the estrous cycle, 
gonadotropins exert their action on follicles or the corpus luteum (CL).  
 LH concentrations slowly increase during the follicular phase and stimulate estradiol (E2) 
secretion from the wave of developing follicles. As the follicular phase progresses, E2 reaches a peak just 
before the preovulatory LH surge, a rapid bulk secretion of LH from the pituitary. The high concentration 
of LH at this time cause ovulation of the preovulatory follicle and then low LH concentrations continue to 
stimulate the CL to produce progesterone during the luteal phase, which lasts approximately 14 days. If 
pregnancy is not achieved following ovulation, the CL regresses and dies, and the cycle starts over.   
 The role of FSH, as described by the name, is to stimulate follicular development and maturation 
of one or more dominant follicles. The process of follicular growth and degeneration occurs throughout 
the entire estrous cycle—not only during the follicular phase. Increasing concentrations of FSH during the 
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early follicular phase stimulate a follicular wave, or recruitment of a group of small antral follicles. All of 
the recruited follicles will begin to grow and secrete E2.  Typically only one or two follicles will develop 
dominance and go on to become preovulatory follicles, while the remaining follicles undergo atresia. 
Once the selected follicles establish dominance, they secrete E2 as well as inhibin which suppress FSH 
secretion from the anterior pituitary, thereby suppressing further follicular recruitment at that time. 
2. The Reproductive Cycle in Rodents 
 In contrast to primates and sheep, rodent estrous cycles are much shorter, lasting only 4-5 days, 
and are made up of four parts: metestrus, diestrus, proestrus, and estrus. Follicles grow and develop 
during metestrus and diestrus, and on the afternoon of proestrus, a rise in E2 leads to the LH surge and 
ovulation. A day of estrus follows, during which time the female is sexually receptive. While the LH 
surge in rodents relies on elevated E2, similar to sheep, progesterone is also necessary for the full LH 
surge in rodents (5). The timing of the rodent LH surge is highly specific as well, with LH concentration 
starting to increase rapidly around 14:00 to 15:00 hours on the afternoon of proestrus, and reaching peak 
levels by 17:00 to 19:00 hours that day (6). Progesterone given early in the morning of proestrus has been 
shown to advance the LH surge by several hours (7). However, this role of progesterone in the surge is 
only observed in rodents. Ultimately, environmental light-dark cycles regulate timing of the surge. The 
light-dark signal is received by the eyes which have neural projections to the suprachiasmatic nuclei 
(SCN) of the hypothalamus (8;9). This environmental input is essential in regulating cyclicity in rats, as 
lesioning of the SCN has been shown to terminate the estrous cycle (10;11).  
 
CONTROL OF GnRH/LH SECRETION PATTERNS ACROSS THE CYCLE 
1. E2 Negative Feedback and Tonic GnRH/LH Secretion 
 Two distinct patterns of GnRH/LH secretion have been identified in sheep (12), rodents (13;14), 
and primates (15). The chronic pulsatile release of LH, referred to as tonic secretion, occurs throughout 
most of the follicular phase and during the luteal phase, and is characterized by brief periods of secretion 
followed by long periods of nonsecretion, which overall results in relatively low concentration of LH 
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secretion. Maintenance of these low, tonic LH levels is accomplished, at least in part, by the inhibitory 
actions of low circulating E2 levels (referred to as E2-negative feedback), that are produced by growing 
ovarian follicles and progesterone from the CL. During the follicular phase, tonic secretion consists of 
GnRH/LH pulses that are high in frequency but low in amplitude, due to low levels of progesterone, 
which typically inhibits pulse frequency, and increasing E2 levels, which inhibits pulse amplitude (16). In 
contrast during the luteal phase, GnRH/LH pulses are low in frequency but high in amplitude (17) since 
progesterone is the dominant hormone during the luteal phase.  
2. E2 Positive Feedback and the GnRH/LH Surge 
 In contrast to tonic LH secretion, the GnRH/LH surge only occurs late in the follicular phase, 
when increasing E2 levels, produced by the preovulatory follicles, become stimulatory to GnRH/LH 
secretion. This brief period surrounding the surge involves a switch to E2 positive feedback. The increase 
in E2 also induces estrus behavior (3). As a result of the LH surge, the preovulatory follicle bursts and the 
ovum is released, a process called ovulation. Post-ovulation, the remaining follicular tissue luteinizes and 
becomes the CL, which synthesizes and secretes progesterone throughout the luteal phase, as previously 
described above.  
THE ROLE OF E2 IN SEASONAL BREEDING 
 Sheep are seasonally reproductive animals that express ovulatory cycles during the shorter days 
of fall and winter (breeding season), but then enter a period of anovulation during the longer days of 
spring and summer (anestrus). Seasonal breeding is thought to be of evolutionary advantage, allowing 
offspring to be born in the spring when the weather is more favorable and food is more abundant. It is 
widely known that sheep respond to changes in photoperiod to time breeding and anestrous seasons. The 
hormonal signal to which ewes respond is the change in release of melatonin from the pineal gland, which 
occurs at a higher rate in darkness (or night). Thereby, the duration of elevation in melatonin release is an 
index of day length. Seasonal breeders, like sheep, are able to interpret the melatonin signal in a way that 
influences GnRH release, although the pathway through which this occurs remains unclear. However, if 
ewes are exposed to extended periods of long days or short days, they will cease responding to daylength, 
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a phenomenon known as “photorefractoriness” (18). This condition reflects an endogenous circannual 
rhythm for onset and offset of the breeding season that is evident in the absence of photoperiodic cues, 
because the rhythms in ewes deprived of photoperiod information become desynchronized, or free-
running (19-21).  
 Seasonal differences in sensitivity to E2 negative feedback appear to underlie seasonal breeding 
patterns in ewes. While progesterone primarily inhibits LH pulse frequency during the breeding season 
(16), E2 is the main inhibitor of LH pulse frequency during the nonbreeding season (22). During anestrus, 
frequency of LH pulses is low in ovary-intact ewes, i.e. one pulse every 8-12 hours (23), a rate that is due 
to an increased sensitivity to E2 negative feedback during this time (24) and one that is generally 
incapable of promoting follicular development.  Thus, this low GnRH/LH pulse frequency underlies the 
temporary quiescence of reproduction during anestrus (25); ovulatory mechanisms remain intact but are 
not activated in the absence of high, sustained E2 secretion. Thus, frequent injections of GnRH that 
increase tonic LH pulse frequency which stimulates estradiol secretion will result in ovulation in 
seasonally anestrus ewes (26;27). Anestrus continues as long as the photoperiod signal can maintain the 
inhibition of LH pulse frequency or until photorefractoriness occurs. During late summer/early fall, 
enhanced sensitivity to E2 declines and pulse frequency increases, leading to a rise in E2, and eventually 
ovulation, beginning a new breeding season.  
 
PATHWAY OF E2 FEEDBACK  
1. Hypothalamic Sites of LH Regulation 
 Halasz and Gorski (28) identified two major neural areas that are critical for normal pituitary 
function in rats. Using knife-cuts through different areas of the hypothalamus, Koves and Halasz (29)  
revealed that placing a cut behind the preoptic area (POA) of rats blocked the LH surge but had no effect 
on tonic LH secretion, from which they proposed that neurons of the POA are necessary for the 
preovulatory LH surge, while those in the medial basal hypothalamus (MBH) are required for tonic LH 
secretion (29). More specifically, the anteroventral periventricular nucleus (AVPV), a portion of the POA 
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that closely borders the third ventricle in rodents, has been determined to regulate the GnRH/LH surge 
since radiofrequency lesions of the AVPV block the surge (30), as do microimplants of an anti-estrogen 
placed in the AVPV (31).  
 While the POA appears to be critical for E2 positive feedback in rodents, it may not be as critical 
in sheep.  Frontal hypothalamic deafferentation in ewes during the breeding season significantly 
decreased the magnitude of the LH surge, but did not interrupt normal ovulation and cycling (32). 
Moreover, increased activation of GnRH neurons, determined using cFos coexpression, occurs in both the 
POA as well as the MBH at the time of the GnRH surge in ewes (33), indicating involvement of both 
areas. cFos is an early, immediate gene product that is produced following the activation of a neuron, 
which has been widely used as an indicator of neuronal activation. The origin of the activation of the 
surge may lie in the MBH, however, since estrogen-containing microimplants placed in or near the 
arcuate nucleus (ARC) of ewes induce an LH surge, while similar implants in the POA do not. This 
indicates that the estrogen positive feedback is exerted in or near the ovine ARC (34). Together, these 
studies suggest that activation of both areas may be required for the full LH surge, but that the MBH 
component alone is sufficient to produce the LH surge that induces ovulation.   
 The tonic LH control center has been identified as the MBH in rodents, as E2 treatment in this 
area has been confirmed to inhibit LH secretion (35;36). More specifically, the ARC has been identified 
as the site of episodic LH regulation using lesion and transection studies (37). Likewise, the ARC has 
been confirmed to be the site of tonic LH secretion in ewes. This was initially determined by the finding 
that knife cuts to the ARC disrupt pulsatile LH secretion, while cuts anterior to the ARC altered tonic LH 
secretion (38;39). Furthermore, GnRH neurons in the MBH, but not the POA, are activated, using Fos as 
an index of neural activation, when episodic LH secretion increases acutely (40). Multi-unit electrical 
recordings in the MBH have revealed bursts that correlated with LH pulses in goats (41). Together these 





2. E2 Receptors 
 For E2 to impact neuronal function within the hypothalamus, there must be estrogen receptors 
(ER) present. While there are two isoforms of ER expressed in the hypothalamus, alpha and beta, ERα 
appears to be the key receptor mediating the hypothalamic effects of E2 on GnRH/LH secretion. ERβ 
knockout mice do not exhibit any alterations in LH secretion, while ERα knockouts exhibit enhanced LH 
secretion, implicating this ER subtype in negative feedback (42). Furthermore, ERβ knockouts maintain 
the ability to produce an E2-induced GnRH surge, while ERα knockout mice do not (43), confirming that 
ERα also is key in E2 positive feedback regulation.   
 Neurons containing ERα mRNA have been found to be concentrated in several hypothalamic 
areas including the POA, ventromedial nucleus, bed nucleus of the stria terminalis, supraoptic nucleus, 
ARC, retrochiasmatic area (RCh), subfornical organ, and lateral septum of sheep (44). Distribution of 
GnRH neurons and ERα expression overlap only in the POA and ARC in sheep (45), rats (46), and 
primates (47). However, few if any GnRH neurons in these species express ERα (45;47-50). Therefore, E2 
feedback on GnRH release, whether positive or negative, is likely indirect and appears to be mediated via 
other hypothalamic neurons.  
3. ERα expression in a specific population of ARC neurons 
 A few populations of hypothalamic neurons have been found to highly express ERα. Of particular 
relevance to this dissertation are those ERα-positive neurons expressing kisspeptin (51), neurokinin B 
(NKB) (48), or dynorphin (DYN) in the arcuate nucleus. Furthermore, it is common that all of these 
neuropeptides are found within the same neurons in the ARC. For example, most DYN neurons in the rat 
ARC express NKB, and vice versa (52), and high levels of colocalization of NKB and dynorphin were 
confirmed in the ovine ARC (53). High levels of coexpression of ARC (known as the infundibular 
nucleus in humans) kisspeptin and NKB has been observed in male rhesus monkeys (54) and humans 
(55). More recently, assessment of colocalization of these three neuropeptides led to the discovery that a 
single population of ARC neurons coexpresses kisspeptin, NKB, and DYN in sheep (56), mice (57), rats 
(52), and goats (41). Thus, this population was assigned the moniker KNDy (58). In humans, 
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colocalization of kisspeptin and NKB in the infundibular nucleus has been confirmed (55), however, a 
recent study from the same lab failed to observe any detectable amounts of DYN in young male subjects, 
challenging the concept of cross species conservation of the presence of KNDy neurons (59). 
 Nonetheless, due to the intimate colocalization of the three peptides within KNDy neurons in 
multiple mammalian species, recent models suggest that these three neuropeptides work together to 
regulate tonic GnRH/LH secretion. Less is known about their possible collusion in regulating the 
GnRH/LH surge. In the following sections, I will consider each of these peptides separately and then 
describe a model regarding their potential interactions in tonic as well as surge LH secretion.  
 
KISSPEPTIN 
1. Discovery  
 The Kiss1 gene was first discovered as a human tumor metastasis-suppressor gene and given the 
name metastin (60). Another group working independently, named the peptide kisspeptin in honor of the 
place it was discovered, Hershey, PA, home of the famous Hershey’s Kiss ™. A member of the RF-amide 
family of neuropeptides, kisspeptin is a 145-amino acid peptide which can be truncated by post-
translational processing to 54, 14, 13, or 10 amino acids, all of which are biologically active (61). Its 
receptor, GPR54 (or Kiss1r), is a G-protein coupled receptor that was originally identified as an orphan 
receptor (62;63). A loss-of-function mutation in GPR54 causes hypogonadotropic hypogonadism in 
humans, as identified in two different consanguineous families (64;65), demonstrating that the kisspeptin-
GPR54 interaction is essential to sexual maturation and fertility in humans. This discovery led to 
kisspeptin being the focus of much attention in the field then, and this interest still remains. 
2. Stimulation of GnRH/LH Secretion  
 Kisspeptin has been confirmed as a potent stimulator of LH secretion in all species that have been 
studied including rodents (66;67), sheep (68;69), monkeys  (70;71), and humans (72;73). Most kisspeptin 
neurons in the ovine hypothalamus express ERα, suggesting that E2 can act directly on kisspeptin neurons 
(51). Furthermore, from the high percentage of colocalization of GnRH neurons and Kiss1r mRNA in 
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both female mice (90%) (74) and ewes (78-90%) (75;76), it appears that kisspeptin can act directly to 
stimulate GnRH neurons 
3. Role of kisspeptin in rodents  
 Two anatomically distinct populations of kisspeptin neurons are present in rodents, one in the 
AVPV and one in the ARC, as identified using both mRNA (66;77;78) and protein (77;79). The AVPV 
population has been confirmed to mediate E2 positive feedback and the GnRH/LH surge based on the 
following reports: 1) infusion of anti-kisspeptin antibody into the POA (80),  and more specifically the 
AVPV (77), abolished the LH surge in rats , 2) Kiss1 expression was reduced in the AVPV after 
ovariectomy, and increased with E2 treatment in mice (78) and rats (77), 3) Kiss1 mRNA levels and 
kisspeptin/c-Fos coexpression are highest in the AVPV on the evening of proestrus at the time of the LH 
surge in rats (81), 4) Kiss1 expression in the AVPV is sexually dimorphic, with female rats expressing 
significantly higher numbers of kisspeptin neurons than their male counterparts (82), an important sex 
difference since males do not typically exhibit LH surges (6). 
  In contrast to the AVPV population, ARC kisspeptin neurons appear to mediate E2 negative 
feedback in rodents. While one study found ARC kisspeptin neurons to exhibit increased Fos mRNA in 
mice during proestrus (80), a more recent study in rats found that kisspeptin neurons in the ARC do not 
express Fos at the time of the LH surge (81). Possible explanations for this discrepancy are: 1) the mice in 
the study by Kinoshita et al were killed early in the afternoon while the rats in the study by Smith et al 
were killed in the evening, so it could be an effect of timing 2) the mouse study used 
immunohistochemistry to detect kisspeptin positive cells while the rat study utilized in situ hybridization 
to detect Kiss1 mRNA, so there could be differences in antibody specificity for kisspeptin. However, 
further research supports a role for ARC kisspeptin in tonic LH secretion. Kisspeptin cell numbers in this 
nucleus are not sexually dimorphic (82), which fits with both males and females exhibiting negative 
feedback regulation of tonic LH secretion by estradiol. Moreover, Kiss1 expression in the ARC increases 
following OVX and decreases with E2 replacement (78). Therefore, it appears that in rodents the AVPV 
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and ARC populations of kisspeptin neurons separately regulate the positive and negative feedback effects 
of E2.  
4. Role of kisspeptin in sheep 
  It is now generally accepted that kisspeptin plays an important role in both pulsatile and surge 
secretion of LH in sheep. Microinjection or microimplants containing Kiss1r-antagonist decrease LH 
pulse frequency in OVX ewes (83), which demonstrates the role of kisspeptin in tonic LH secretion. 
Similarly, ICV infusion of a kisspeptin receptor antagonist reduced the LH surge amplitude in ewes by ~ 
50% (76), indicating that kisspeptin is important for the LH surge, but it may not be solely responsible for 
it. These data also raise the possibility that other neuropeptides are involved in stimulating the full LH 
surge, although it is possible that the high dose of antagonist used in this experiment was not sufficient to 
block all of the Kiss1r and the remaining receptors were able to maintain half of the LH surge. 
 In ewes, kisspeptin-ir neurons are located in two distinct areas, the ARC (51;84;85) and POA 
(51;85). Unlike rodents, sheep do not have a clearly defined AVPV, and ovine kisspeptin neurons are 
found more loosely scattered within the POA.  In sheep, tonic and surge regulation of LH does not seem 
to be as clearly separated between kisspeptin populations as it is in rodents.   
 The majority of kisspeptin neurons are found in the ARC and OVX increases, while E2 treatment 
decreases, Kiss1 mRNA in this area (75;85), implicating the ARC population in negative feedback 
regulation by E2. Furthermore, this population may also play a role in E2-positive feedback during the 
preovulatory GnRH surge. Kiss-1 mRNA expression was shown to be elevated in the caudal ARC during 
the LH surge (84), and the percentage of kisspeptin neurons coexpressing Fos, an index of neuronal 
activation, in this area increases 1 h after surge-inducing E2-treatment (75). However, contradictory data 
show that during the LH surge, less than 5% of kisspeptin neurons coexpress Fos in the ARC (86). As 
mentioned above, it is important to note that E2 treatment in this area has been shown to induce an LH 
surge (34), so ARC kisspeptin neurons may only be involved in the initiation of the surge.  
 Although the MBH appears to be important for generation of the GnRH surge in sheep, the role 
of the POA remains unclear. At one hour after surge-inducing E2 treatment in OVX ewes, there was no 
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change in kisspeptin/Fos coexpression in the POA; in contrast, during the late follicular phase in intact 
cycling ewes, Kiss1 mRNA was significantly increased in the POA (75) and E2 increases kisspeptin 
expression in OVX ewes(87). Using a surge model, ~50% of POA kisspeptin neurons were found to 
coexpress Fos at the time of the surge (26 h post-E2 treatment) while nearly none express Fos during tonic 
secretion in the luteal phase (86). Together, these data indicate that POA kisspeptin neurons may be 
important regulators of surge, but likely not tonic LH secretion in ewes. However, the role of ARC 
kisspeptin neurons remains controversial. Therefore, the first aim of my thesis was to assess which 
population of kisspeptin neurons mediates E2-negative and E2-positive feedback in ewes.  
 
NEUROKININ B 
1.  Discovery 
 NKB is a member of the tachykinin family of neuropeptides, which also includes substance P 
(SP) and neurokinin A, among others. Tachykinins are peptides that contain the sequence Phe-X-Gly-
Leu-Met-NH2 at their carboxyl terminus, with the “X” being variable (88). Two genes encode for the 
family of tachykinins, with TAC3 specifically encoding the precursor for NKB (89). The tachykinins bind 
to the rhodopsin-like family of G-protein-coupled receptors (NK1R, NK2R, or NK3R) which share 
similar structures (90;91). Substance P and neurokinin A preferentially bind to NK1R and NK2R, 
respectively, while NKB has the highest affinity for NK3R. However, each of these tachykinins can 
interact with the other receptors when present at high concentrations (92-94). For most of the experiments 
herein I used senktide, an agonist that is highly specific for the NK3R receptor subtype (95).  
2. Stimulation of GnRH/LH Secretion    
 NKB neurons are located mostly in the infundibular nucleus and the anterior hypothalamic area in 
humans (96). The first evidence for NKB playing a role in regulating LH secretion was reported in the 
early 1990’s, when it was observed that a population of neurons in the infundibular nucleus of post-
menopausal women highly expressing ERα and NKB were found to be hypertrophied compared to these 
neurons in pre-menopausal women (97). Since menopause is associated with ovarian senescence, 
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resulting in decreased E2 secretion and thus low negative feedback and elevated LH secretion, this finding 
indicated that the hypertrophy of NKB neurons may be responsible for the increased LH secretion. 
However, NKB’s role in regulating LH release received only limited attention until it was discovered in 
2009 that loss-of-function gene mutations in NKB (TAC3) or its receptor (TACR3) in humans result in 
infertility (98), thus clearly demonstrating that NKB is essential to human reproduction.  Treatment of 
males that express NKB or NK3R mutations with exogenous GnRH (99;100) or kisspeptin (101) restores 
fertility, suggesting that NKB acts via GnRH, either upstream of kisspeptin or independent of kisspeptin 
signaling.  
3. Role of NKB in rodents 
 Neurons expressing NKB mRNA (57;102-104) or protein (102-106) are found scattered 
throughout the hypothalamus and POA in rodents, with the majority of cells bodies found in the ARC. As 
is observed in humans, NKB cell numbers and gene expression in rodents are modulated by ovarian 
hormones, with numbers of detectable NKB neurons in ovary-intact rats being highest on the morning of 
proestrus and NKB expression increasing after OVX (107), relationships which suggest that NKB 
stimulates LH secretion in rodents. However, ICV injection of an NK3R agonist (senktide; 600 pmol/3 
μl) was found to inhibit LH secretion in OVX + E2 rats (108). These initial conflicting results led to 
decreased interest in NKB as being important for regulating reproduction until the aforementioned loss of 
function mutation in humans was discovered.  
 Recent studies using rodents have consistently found that NK3R agonists stimulate LH secretion 
in gonadal intact mice (109;110) and rats (111;112), and inhibit LH secretion in OVX mice (57) and rats 
(111;112). The results of NK3R agonists in OVX + E2 rodents are inconsistent, with no effect having 
been reported in mice (57) and either inhibition or stimulation in rats (108;111;112). Together these data 
lead to the conclusion that the effects of senktide (and presumably NKB) in rodents are dependent on 
steroid milieu (112). An important note on NKB in rodents is that NK3R-deficient mice remain fertile 
(113), albeit they are “sub-fertile” with a decrease in litter number as well as litter size (114). Thus, NKB 
may be less important in rodent reproduction than it is in humans and perhaps other species. 
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4. Role of NKB in sheep 
 Neurons expressing NKB mRNA (48;115) and protein (48;53;56) are found virtually exclusively 
in the ARC, and 97% coexpress ERα (48). NKB appears to be regulated by estrogen in a negative 
manner, with OVX increasing NKB cell number in ewes (116) and short-term E2-treatment in OVX ewes 
inhibiting NKB mRNA expression and NKB-ir cell numbers (115). A stimulatory effect of NKB on LH 
secretion in ewes was confirmed by giving senktide via ICV injection in follicular phase or anestrous 
ewes (117) and ICV infusion of NKB in anestrous ewes (118). Additionally IV injection of senktide 
increases LH secretion in prepubertal female lambs (116). Thus, in contrast to the rodent data, work to 
date in the sheep indicates that senktide is stimulatory to LH secretion in follicular phase and OVX ewes, 
but has no effect in luteal phase ewes (117). This effect likely occurs exclusively through modulation of 
GnRH release since blocking GnRH actions at the anterior pituitary with a GnRH receptor antagonist also 
blocks the stimulation of LH release by senktide (116). 
5. Possible NKB Sites of Action 
 NK3R expression is highest in four areas of the ovine hypothalamus; the RCh, ARC, POA, and 
PVN. The POA is also the location of most GnRH cell bodies; however, GnRH neurons in this area do 
not express NK3R (119). As previously mentioned, the ARC is thought to be the main site of E2 negative 
feedback in ewes and KNDy neurons in this area have been confirmed to coexpress NK3R (119), raising 
the possibility of autocrine or paracrine regulation of that population to possibly drive pulsatile LH 
secretion.  
 NKB-positive fibers with close appositions to GnRH cell bodies in sheep (48) and GnRH 
terminals were observed in the median eminence of sheep (53), rats (120), mice (57), and goats (41). 
However, the presence of NKB receptors on GnRH neurons in mice is unclear, as one study reports that 
GnRH neurons express Tac3r (121) and another report that no coexpression was found (112). Another 
study has reported low levels of NK3R expression in GnRH neurons in rats (120), but similar studies in 
sheep found no expression of NK3R on GnRH neurons (119). Therefore, the ability of NKB to directly 
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act on GnRH neurons remains unclear. At least in male mice, senktide depolarizes kisspeptin neurons but 
not GnRH neurons in tissue slice preparations (110). 
 Our laboratory recently reported that senktide given in the RCh stimulates LH secretion in ewes, 
indicating that NK3R activation in this area is involved in regulating LH release (117). Interestingly, the 
increase in LH secretion did not seem to reflect an increase in LH pulse frequency, but instead was 
similar in profile to that seen during the LH surge, suggesting that NKB may have a role in E2 positive 
feedback as well. Lastly, the PVN has been documented as a site of LH control in fasted OVX rats, with 
local E2 treatment suppressing both mean plasma LH and LH pulse frequency (122). The effects of NKB 
or senktide in the POA, PVN, and ARC have not yet been evaluated. Therefore, the second aim in my 




 The final KNDy neuropeptide to be discussed is dynorphin A (DYN). First identified in the 
pituitary (123-125), DYN is a member of a family of endogenous opioid peptides (EOPs), and is derived 
from the prodynorphin precursor. Other EOPs include the endorphins, such as β-endorphin, and the 
enkephalins. DYN is now known to play a role in regulating GnRH/LH secretion in response to changes 
in circulating levels of gonadal steroids.  
 DYN neurons in the rat POA (126) and sheep POA, ARC, and anterior hypothalamus (127) 
highly express progesterone receptors (PR). Progesterone treatment has been shown to increase cerebral 
spinal fluid DYN concentration in OVX ewes (128). Furthermore, most ARC DYN neurons have been 
found to highly express ER-α in rats (52), which has also been inferred in sheep since all PR-positive 
neurons have previously been found to also express ERα (129). 
2. DYN- κ-opioid receptor (KOR) interaction 
 EOPs act via three receptor subtypes: κ-, μ-, and δ-. Dynorphin is the endogenous ligand for KOR 
(130) while endorphins and enkephalins have the highest affinity for binding to μ-, and δ-receptors (131). 
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Most MBH GnRH neurons receive close contacts from DYN-containing varicosities in sheep (132) and 
rats (133). No μ- or κ-receptors were found to be coexpressed in GnRH neurons in female rats (133;134). 
Functional δ-opioid receptors have been identified in a neuronal GnRH-producing cell line from mice 
(135). However, KOR have been shown to inhibit LH secretion in rats (136) and KOR antagonists 
increase LH in sheep (132). 
3. LH Surge Regulation by DYN 
 EOPs are now generally thought to play an important role in the inhibitory control of GnRH/LH 
secretion, and removal of the inhibition, termed ‘disinhibition’, has been postulated to play a role in 
GnRH/LH surge regulation. Central infusion of a μ-receptor agonist, but not a κ- or δ-agonist, delayed the 
LH surge in OVX ewes (137). This effect appears to be mediated at both the level of the POA or the 
MBH as bilateral infusion of a μ-receptor agonist in either of these areas significantly delays the LH surge 
(138). However, the EOP antagonist naloxone does not advance the LH surge in sheep (139;140), 
suggesting that DYN does not appear to play a critical role in regulating the surge in sheep.  
 In support of the disinhibition hypothesis in rodents, blockade of KORs in the POA of rats on 
proestrus advanced the LH surge by 3 h (141). Treatment with DYN or KOR-agonists via ICV infusion 
blocks the endogenous LH surge on the afternoon of proestrus in rats (142). Therefore, disinhibition of 
DYN appears to be essential for the normal preovulatory LH surge in rats. The underlying control of this 
phenomenon remains unclear. However, it has been observed that KOR mRNA levels in the POA do not 
change during proestrus or diestrus while prodynorphin mRNA in the POA decreases at 1700-1800 h on 
proestrus compared to levels at 1300-1400 h (143), indicating that the disinhibition is likely a result of 
decreased DYN release.  
4. Negative Feedback Regulation on LH Secretion by DYN 
 EOP antagonists failed to alter LH secretion in OVX or E2-treated OVX ewes, but significantly 
increased LH in OVX + progesterone ewes (144;145), suggesting that EOPs mediate the negative 
feedback actions of progesterone but do not mediate effects of E2. Specifically, EOPs that act via μ-
receptors and KOR have been implicated in mediating progesterone negative feedback in rodents 
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(146;147) and sheep (132). Targeted extracellular recordings of KNDy neurons revealed that DYN 
decreases spontaneous neuron activity in intact mice (148). Recent work from our lab has shown that a 
KOR antagonist treatment in the ARC increases LH pulse frequency in OVX ewes, indicating that 
dynorphin can mediate progesterone-independent LH regulation (83). This phenomenon has also recently 
been reported in E2-treated OVX rats (149), which suggests that dynorphin may also mediate some type 
of E2 negative feedback. In conclusion, while DYN is widely accepted as an inhibitor of LH secretion 
across species, the pathway through which it acts, as well as the influence on its actions by steroid 
hormones, remains under investigation.                      
             
THE KNDy NEURAL NETWORK 
1. KNDy-GnRH Neuron Interaction 
 As discussed above, all three neuropeptides expressed in KNDy neurons have been identified as 
playing important roles in the regulation of GnRH secretion; therefore, the interaction between KNDy and 
GnRH neurons is of considerable interest. Because the colocalization of these three peptides has been 
observed only in the ARC, ICC labeling for multiple KNDy peptides within the same terminals was 
utilized to identify targets of KNDy output. In ewes, KNDy fibers were observed in close contact with 
GnRH neurons in both the POA and the MBH (58). This finding is consistent with previous data showing 
that kisspeptin, NKB, or dynorphin fibers alone have direct input to GnRH neurons in rats (80;150), mice 
(79), and sheep (132), as well as in humans (151). However, in those studies, it cannot be concluded that 
the projections are coming from KNDy neurons, since only one peptide was assessed and these peptides 
are independently expressed in various areas of the brain. KNDy neurons have also been shown to project 






2. Reciprocal Innervations amongst KNDy Neurons 
 When considering how KNDy neurons act to regulate GnRH release, one interesting feature of 
this population is that almost all of them receive input from other KNDy neurons. Specifically, dual-
labeling revealed that NKB/DYN-positive fibers form close contacts with NKB/DYN-positive cell bodies 
in the ovine ARC (53). Since NKB expression is limited to the ARC in sheep, this innervation can only 
come from other ARC KNDy neurons.  Similar findings have been reported for rats (52). KNDy neurons 
have been confirmed to express NK3R in sheep (119). Furthermore, tract tracing studies have identified 
NKB-positive axons in the ARC terminating on other NKB-ir neurons in the same area and upon KNDy 
neurons in the contralateral ARC in rats (105) and goats (153).    
 These data strongly support the feasibility of KNDy neurons acting as a reciprocal network via 
local NKB and possibly DYN secretion.  Given what is known about locations of receptors for the 
various KNDy peptides and this reciprocity, it has been hypothesized that NKB and dynorphin may act in 
a paracrine or autocrine fashion to regulate kisspeptin output, which then influences GnRH release.  
  KNDy neurons in rats express NK3R (52) and in mice KNDy neurons express both NK3R and 
low levels of KOR (57), suggesting the interaction of the KNDy neuropeptides is similar to that in sheep. 
However, data from studies on DYN yield varying results. Ovarian steroids have been shown to inhibit 
prepro-DYN mRNA in the ARC of mice, and KOR knockout was found to decrease LH secretion in 
OVX mice (57). Therefore the role of DYN in rodents remains unclear.  
3. NKB May Act via Kisspeptin 
 Certain aspects of this hypothesis have been tested using pharmacological approaches. Support 
for the idea that NKB acts upstream of kisspeptin in rodents lies in the finding that senktide injection in 
OVX + E2 rats activates ARC kisspeptin neurons, as indicated by increased Fos colocalization (112), and 
that senktide stimulates LH secretion in wild-type male mice but has no effect on LH release in Kissr1 
knockout counterparts (109). Recent work indicates that senktide administration in OVX rats may inhibit 
LH secretion via a KOR-dependent mechanism, possibly by recruiting DYN to activate the KOR (154), 
further suggesting an intimate interaction occurs between neuropeptides within the KNDy neural network 
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in rodents. Additionally, work in primates found that down-regulation of Kiss1r abolished the senktide-
induced stimulation of GnRH secretion, indicating that NKB action upstream of kisspeptin is likely 
conserved across species (155).  
 In ewes, ICV infusion of NKB increases activation of kisspeptin neurons in the caudal ARC of 
anestrous ewes (118), although where NKB acts within the hypothalamus to do this cannot be determined 
using this approach. Nonetheless, these findings support the hypothesis that NKB is altering GnRH/LH 
secretion via kisspeptin release from KNDy neurons.  
 While the findings from these aforementioned studies postulated that NKB is acting directly upon 
KNDy neurons to increase kisspeptin, it is also possible that kisspeptin mediates NKB action in other 
areas of the hypothalamus. This hypothesis will be addressed in my final aim, by assessing both ARC and 
POA kisspeptin neuron activation following NKB or senktide treatment in various areas of the 
hypothalamus.  
4. KNDy Neurons as the Pulse Generator: Current Ovine Model 
 Many facets of data have been combined to postulate a current model for the GnRH pulse 
generator in ewes and goats. Studies assessing multi-unit electrical activity (MUA) recorded near KNDy 
neurons in goats have shown that MUA volleys recorded in the ARC coincide with LH pulses (41). This 
MUA data together with the anatomical observations and pharmacological evidence regarding KNDy 
neurons gives rise to a model for GnRH/LH pulse generation. Kisspeptin is suggested to be the output 
from the KNDy neuron network to GnRH neurons in both the POA and MBH. Kiss1r expression in 
GnRH neurons along with data in mice showing that kisspeptin application directly excites GnRH 
neurons (156) strongly indicate that kisspeptin acts directly to influence GnRH release. However, it is 
possible that other more indirect pathways are involved as well. The currently proposed model (Figure 
1A) for KNDy neuron regulation of GnRH secretion in sheep involves NKB and DYN acting within the 
KNDy network while kisspeptin serves as the output from KNDy neurons to GnRH neurons (58). Further, 
a model for the switching on/off of pulses within the KNDy network has been proposed (Figure 1B)(58). 
This model suggests that the interplay between peptides may underlie GnRH pulse generation, i.e.  NKB 
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release from KNDy neurons likely stimulates other KNDy neurons through extensive reciprocal 
innervations, ultimately causing kisspeptin release which acts to stimulate GnRH release and initiate pulse 
onset. Dynorphin may then serve as the brake to terminate the pulse of GnRH secretion. Recent  data 
from our laboratory demonstrated that ARC administration of either a Kiss1r antagonist or an NKB 
receptor antagonist inhibited LH pulse frequency while NKB or an antagonist to KOR increased LH pulse 
frequency in OVX ewes, supporting the roles that have been previously proposed for each of these 
neuropeptides in the pulse generator model (157). Also, administration of either senktide or nor-BNI 























Figure 1: A) Schematic of the current model for KNDy neuron interaction with GnRH 
neurons.  B) Model describing the role for NKB and DYN in LH pulse regulation (from 










5. KNDy Neurons as the Preovulatory Surge Regulator: Current Ovine Model 
 For E2-positive feedback, the current working hypothesis is that high levels of E2 also act on the 
KNDy neurons in a stimulatory fashion to trigger a sequence of events that differ from those that occur 
during negative feedback. Increased Fos expression in KNDy neurons, but not POA kisspeptin neurons, 
was observed at 1 h after injection of a surge-inducing dose of E2 in ewes and Kiss1 mRNA is elevated in 
the POA kisspeptin neurons during the late follicular phase (75), indicating that the initial effects of E2 on 
KNDy neurons may lead to later activation of POA kisspeptin neurons during the LH surge. Furthermore, 
several other neurotransmitters have also been implicated in the control of the GnRH/LH surge (3). VMN 
somatostatin neurons express ER-α (158), and E2 treatment has been shown to increase somatostatin 
mRNA during the LH surge (159). Somatostatin neurons also highly express Fos during the surge (158); 
however, E2 treatment in the VMN failed to induce Fos in these neurons (160). Furthermore, somatostatin 
treatment in OVX ewes inhibited LH secretion (159), conflicting with the idea that somatostatin may play 
a role in inducing the LH surge. 
 Norepinephrine (NE) has also been postulated to play a role in surge regulation, since E2 increases 
Fos expression in A1 NE neurons in ewes (161). Concentrations of NE increase in the ME during the 
GnRH surge (162), further indicating a role for NE involvement in the surge. However, treatment with an 
adrenergic antagonist was unable to consistently block an E2-induced LH surge (163), suggesting 
endogenous NE may not play a vital role in the LH surge.  
 The involvement of these and other neurotransmitters in surge regulation suggests the likely 
possibility that that E2 acts via multiple pathways and in several areas within and without the 
hypothalamus to induce the preovulatory GnRH surge. The possible involvement of NKB in the LH surge 
is unknown. Therefore, elucidating that role is the overall aim of this dissertation, which is broken-down 







Specific Aim 1: Determine which population of kisspeptin neurons mediates E2-negative and E2-
positive feedback. 
  We will address this aim by evaluating if the POA and/or ARC population of kisspeptin neurons 
are activated, as determined by coexpression of cFos, either by decreased E2-negative feedback 
(following ovariectomy, when LH pulse frequency is high) or during an E2-induced LH surge. 
 
Specific Aim 2: Determine in which area(s) of the hypothalamus activation of NK3R induce surge-
like LH secretion and which of these are important for the LH surge.  
 We will address this aim by placing NKB or senktide the RCh, POA, PVN, and ARC and 
examining LH secretion. Next, we will determine if activation of NK3R in the areas where we observe a 
response to senktide is necessary for an E2-induced surge by placing an NK3R antagonist into these areas 
during an E2-induced LH surge.  
 
Specific Aim 3: Determine if NKB acts via kisspeptin and/or through alternative pathways to alter 
LH secretion. 
 This aim will be addressed by two approaches: 1) determine whether activation of NK3R in 
specific hypothalamic areas increases Fos expression in KNDy neurons or POA kisspeptin neurons, in 
conjunction with stimulating LH secretion, 2) determine if blocking Kiss1r alters the senktide-induced 
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 KNDy (kisspeptin/neurokinin B/dynorphin) neurons of the arcuate nucleus (ARC) appear to 
mediate the negative feedback actions of estradiol and are thought to be key regulators of pulsatile LH 
secretion. In the ewe, KNDy neurons may also be involved with the positive feedback actions of estradiol 
(E2) to induce the LH surge, but the role of kisspeptin neurons in the preoptic area (POA) remains 
unclear. The goal of this study was to identify which population(s) of kisspeptin neurons is (are) activated 
during the LH surge and in response to the removal of E2-negative feedback, using Fos as an index of 
neuronal activation. Dual-label immunocytochemistry for kisspeptin and Fos was performed on sections 
containing the ARC and POA from ewes during the luteal phase of the estrous cycle, or before or after 
onset of the LH surge (experiment 1), and from ovary-intact, short-term (24h) and long-term (>30 d) 
ovariectomized (OVX) ewes in anestrus (experiment 2). The percentage of kisspeptin neurons expressing 
Fos in both the ARC and POA was significantly higher during the LH surge. In contrast, the percentage 
of kisspeptin/Fos colocalization was significantly increased in the ARC, but not the POA, after both 
short- and long-term E2 withdrawal. Thus, POA kisspeptin neurons in the sheep are activated during, and 
appear to contribute to, E2-positive feedback, whereas ARC kisspeptin (KNDy) neurons are activated 
during both surge and pulsatile modes of secretion and likely play a role in mediating both positive and 













Although the importance of gonadotropin-releasing hormone (GnRH) in reproduction is well 
known, identification of the pathways through which estradiol (E2) regulates GnRH release remains an 
area of continuing investigation. Ovarian steroids exert negative feedback on GnRH/LH secretion 
throughout the luteal and early follicular phase of the estrous cycle (1). During the breeding season of 
ewes, E2 serves to inhibit LH pulse amplitude while progesterone inhibits pulse frequency (1, 2); 
however, during anestrus (non-breeding season), E2 inhibits LH pulse frequency (3). In contrast to these 
inhibitory effects, the preovulatory GnRH/LH surge that occurs at the end of the follicular phase is 
induced by high levels of E2 secreted from preovulatory follicles (4). Estrogen receptor-α (ERα) is the key 
receptor in mediating regulation of GnRH by E2 (5). Because few, if any, GnRH neurons express ERα (6), 
the feedback actions of E2 must occur via other neurons, and recent work points to kisspeptin neurons as 
playing a key role in this function. Importantly, most kisspeptin neurons express ERα (7) and can directly 
interact with GnRH neurons, 90% of which express the kisspeptin receptor (8-10). 
  Kisspeptin, a member of the RF-amide family of neuropeptides, binds to its receptor, GPR54 
(11, 12), and stimulates LH release in humans (13) as well as in mice (14), rats (15, 16), sheep (17), and 
primates (18). A mutation in GPR54 causes hypogonadotropic hypogonadism in humans (19, 20), 
indicating the importance of the kisspeptin-GPR54 interaction in controlling sexual maturation and 
reproduction.  Kisspeptin has now been identified as a key regulator of GnRH and LH secretion and has 
been proposed to mediate both negative and positive feedback actions of E2 (21, 22). 
 Two anatomically distinct kisspeptin populations exist in rodents. Those in the anteroventral 
periventricular nucleus (AVPV) have been proposed to mediate the E2-induced GnRH/LH surge (23, 24), 
while kisspeptin neurons in the arcuate nucleus (ARC) are thought to be responsible for E2-induced 
inhibition of episodic GnRH/LH secretion (21, 24-26).  Sheep do not have a distinct AVPV, but 
kisspeptin neurons are evident in both the preoptic area (POA) and ARC, with some anatomical 
differences between the two populations. Almost all kisspeptin neurons in the ARC coexpress dynorphin 
and neurokinin B and, hence, are referred to as KNDy neurons (27). More than 90% of these neurons 
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receive input from other KNDy neurons, thus forming an interconnected, reciprocal network with one 
another (28-30). POA kisspeptin neurons in sheep do not exhibit colocalization with dynorphin or 
neurokinin B, and do not exhibit the same degree of reciprocal connections with each other as seen among 
KNDy neurons. There also may be functional differences between these two kisspeptin-containing neural 
populations.   The effects of E2 removal (22) and replacement (10, 22) on Kiss1 mRNA expression 
implicate ARC kisspeptin neurons as important mediators of E2-negative feedback. However, the role of 
both POA and ARC kisspeptin neurons in the preovulatory LH surge remains unclear. During late 
follicular phase, elevated Kiss1 mRNA expression has been observed in both the POA and some regions 
of the ARC (10). However, studies using Fos to analyze neuronal activation of kisspeptin neurons have 
been inconclusive (10, 31). The purpose of this study was to determine which population(s) of kisspeptin 
neurons are activated during the LH surge and in response to removal of E2-negative feedback, using Fos 
as an index of neural activity. Because anatomical subsets of ARC kisspeptin neurons have been 
implicated in the surge (10), and to assess the possibility that different ARC kisspeptin neurons might be 
dedicated to surge and tonic GnRH secretion, we analyzed Fos expression in rostral, middle, and caudal 
portions of the ARC, as has been done in previous work (10). 
 
Materials and Methods 
Animals 
Adult blackface ewes were maintained under ambient conditions in an open barn with free access 
to food and water. Three to five days before any experimental procedures, ewes were moved to an indoor 
facility with controlled photoperiod simulating natural outdoor day length. In this facility, they had free 
access to water and a mineral lick and were fed a pelleted maintenance diet daily. Estrous behavior was 
determined using vasectomized rams.  Blood samples (3-5 ml) were taken by jugular venipuncture, placed 
into heparinized tubes, and plasma collected and stored at -20 C. Ewes used for experiment 1 were killed 
during the breeding season (Oct.-Feb.), and ewes used in experiment 2 were killed during the non-
breeding season (May through July). All experimental procedures involving animals were approved by 
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the West Virginia University Animal Care and Use Committee, and followed the National Institutes of 
Health guidelines for animal research.  
 
Animal Protocol 
Experiment 1.  Which kisspeptin neurons are activated during the preovulatory LH surge? 
   To collect tissue from ewes at specific times of the estrous cycle, their cycles were synchronized 
with im injections (10 mg) of prostaglandin F2α (PGF2α; Lutalyse; Upjohn, Kalamazoo, MI) to induce 
regression of the corpus luteum. Once cycles were synchronized, brain tissue was collected on d 9-10 of 
the luteal phase (n=4) or PGF2α was again injected and two controlled internal drug releasing (CIDR) 
devices were inserted to maintain luteal phase progesterone concentrations (32). Ten days later, the 
CIDRs were removed and blood samples were collected every 4 h starting 12 h after CIDR removal until 
perfusion. Tissue was collected 4 h after onset of estrous behavior and, based on LH concentrations, 
animals were classified into pre-surge (n=11) and surge (n=5) groups.  One ewe included in the surge 
group was estrous-synchronized with only PGF2α (i.e., CIDRs omitted) and was killed during a clear LH 
surge.   
  
Experiment 2.  Which kisspeptin neurons respond to removal of E2 negative feedback? 
  This experiment was performed in anestrus, when E2 is the only ovarian steroid inhibiting GnRH 
pulse frequency (2, 3). Bilateral ovariectomies were performed via midventral laparotomy using sterile 
procedures on ten anaesthetized (isofluorane) ewes as previously described (33). Tissue from the short-
term OVX group (n=5) was collected at 24 h post-OVX, and tissue from the long-term OVX group (n=5) 
was collected at least 1 month post-OVX.  Tissue from ovary-intact anestrous ewes (n=5) was also 
collected. Blood samples were collected every 12 min for 4 h just before tissue collection in all three 





 Tissue collection and processing was performed as previously described (27). Ewes were euthanized 
via an iv overdose of sodium pentobarbital (~2g in 7ml saline; Sigma, St. Louis, MO) after two iv 
injections of heparin (25,000 U), 10 min before and immediately before pentobarbitol. The head was 
removed and perfused through both carotid arteries with 6 liters of 4% paraformaldehyde containing 10 
U/ml heparin and sodium nitrate. After perfusion, brains were removed, and POA/hypothalamic tissue 
was dissected out. The tissue was then infiltrated with 30% sucrose, and coronal sections (50 µm thick) 
were cut on a freezing microtome and stored at -20 C in cryoprotectant for later processing.  
 
Assays 
 LH was measured in duplicate aliquots of 50-200 µl of plasma, using a previously validated RIA (33), 
and expressed in terms of NIH-LH-S12. The minimal detectable concentration of LH in these assays 
average 0.077 ng/tube; inter and intraassay coefficients of variation were 3.8% and 1.7%, respectively.  
Circulating progesterone was measured in duplicate aliquots of 150 µl plasma using a commercially 
available solid- phase RIA kit (Coat-A-Count P4, Diagnostic Products, Corp., Los Angeles, CA), which 
has been validated in sheep (34) to confirm stage of cycle.  
 
Immunocytochemistry for kisspeptin and Fos 
  All immunohistochemistry was carried out on free-floating sections at room temperature, and 
sections were washed with 0.1 м PBS between incubations. For all experiments, tissue sections were first 
incubated in hydrogen peroxide (10 min in PBS; EMD Chemicals, Inc., Gibbstown, NJ) to occupy 
endogenous peroxidase sites, followed by incubation in a solution containing 20% normal goat serum 
(Jackson Immunoresearch Laboratories, Inc., Gibbstown, NJ) in PBS containing 0.4% Triton X-100 
(Fisher Scientific, Pittsburgh, PA) for 1 h to minimize nonspecific binding.  
  A dual-label immunoperoxidase procedure was then performed on a series of every fifth POA and 
ARC section in each animal. Fos-ir nuclei were detected using a rabbit polyclonal antibody against c-Fos 
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(1:1,000 (Exp. 1) or 1:2500 (Exp. 2); sc-52, Santa Cruz Biotechnology, Inc.) for 17 hr, followed by 
incubation with biotinylated goat anti-rabbit IgG (1:500; Jackson Immunoresearch Laboratories, Inc.) for 
1 h  and avidin-biotin-horseradish peroxidase complex (ABC-elite; 1:500; Vector Laboratories, 
Burglingame, CA) for 1 h. Labelling was visualized using nickel-enhanced diaminobenzidine (Sigma) as 
the chromogen, producing a black/purple reaction product that is limited to the nucleus. For detection of 
kisspeptin, sections were incubated for 17 h in polyclonal rabbit anti-kisspeptin-10 serum (1:100,000 
(Exp. 1) or 1:50,000 (Exp. 2); #564, gift from A. Caraty, Université Tours, Nouzilly, France) for 17 h, an 
antibody that has been previously validated for use in sheep tissue (27, 35). Following incubation in 
primary antiserum, tissue was labelled with biotinylated goat anti-rabbit IgG (1:500; Jackson 
Immunoresearch Laboratories, Inc.) and ABC-elite (1:500; Vector Laboratories) for 1 h each. Kisspeptin 
was visualized using diaminobenzidine as the chromogen, which produced a brown reaction product 
within the cytoplasm. Sections were then mounted onto Superfrost slides, air-dried, dehydrated, and 
coverslipped using Depex (DPX; Electron Microscopy Sciences, Hatfield, PA).   
  For each ewe, the numbers of single kisspeptin and dual-labeled kisspeptin/Fos cells were 
counted under bright field illumination in the POA (three sections per ewe) and ARC (three sections per 
rostral, middle and caudal subdivisions in each ewe) by an independent observer. POA sections selected 
for analysis were those at the rostral-caudal level of, and just posterior, to the organum vasculosum of the 
lamina terminalis.  For selection of ARC sections, the rostral ARC was defined as that level of the 
nucleus anterior to the appearance of the tubero-infundibular sulcus; the middle ARC was at the level of 
the tubero-infundibular sulcus; and the caudal ARC was at the level of the mammillary recess of the third 
ventricle. To assess the possibility of functionally distinct subsets of ARC kisspeptin neurons, we 
analyzed all three rostral-caudal levels of the ARC to account for the possibility that there may be 
regional differences within the ARC in the functional activation of kisspeptin cells during the surge.  To 
assist with analysis, bright-field images were captured using a cooled charge-coupled device camera 
(Microfire, Optronics, Goleta, CA) attached to a Leica microscope (DM5000B, Leica Microsystems, 
Weztler, Germany) and Neurolucida software (MicroBrightfield, Inc., Williston, VT) with fixed camera 
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settings for all animals; a transparent grid was then placed over the printed images to aid with counting.  
A cell was considered dual labeled when brown kisspeptin-positive cytoplasm was seen to surround a 
black Fos-positive nucleus in the same plane of focus, and the percentage of dual labeling was calculated 
as the total number of dual-labeled cells divided by the total number of kisspeptin-positive cells.  
 
Statistical Analysis 
 The mean number of single-labeled kisspeptin and dual-labeled kisspeptin/Fos cells in each 
region (POA and rostral, middle and caudal subdivisions of the ARC) were counted for each animal, and 
the percentage of kisspeptin cells containing Fos was calculated.  The mean and SEM were calculated for 
each group, and one-way ANOVAs were conducted within each region between luteal, pre-surge, and 
surge groups (Exp. 1), and intact, 1 d OVX, and chronic OVX groups (Exp. 2).  Post hoc analyses of all 
pairwise comparisons were computed using Tukey tests to account for the problem of multiple 
comparisons. In experiment 2, LH pulses were identified using standard criteria (1) and statistically 
significant differences in  mean LH concentrations analyzed by one-way ANOVA and in LH pulse 
frequencies by Kruskal-Wallis one-way ANOVA on ranks. 
 
Results  
Experiment 1: which kisspeptin neurons are activated during the preovulatory LH surge?  
  As expected, mean LH concentrations at perfusion in surge animals increased by seven and five 
fold from luteal and pre-surge groups, respectively (P < 0.05) (Figure 1B).   
 Anatomically, kisspeptin perikarya were localized to the POA and ARC, with the greatest numbers of 
cell bodies seen within the middle ARC and the fewest number of cell bodies in the POA (Figure 2A).  In 
the middle ARC, pre-surge animals had significantly greater numbers of kisspeptin cells compared with 
luteal phase animals, but not surge animals (P < 0.05; Figure 2A). There were no significant effects of 
stage of cycle on kisspeptin cell numbers in any other area. In addition, we noted that labeling of 
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kisspeptin-ir fibers appeared more intense in the pre-surge animals compared with the surge animals 
(Figure 2C).   
  Surge animals showed a significantly greater percentage of kisspeptin cells colocalizing Fos 
compared to both luteal and pre-surge animals throughout the rostral, middle and caudal divisions of the 
ARC (P< 0.05; Figure 2B) and in the POA (P< 0.05; Figure 2B).  The percentage of kisspeptin cells that 
colocalized Fos in each region of surge animals was consistent, ranging from 44 to 61% in the both ARC 
(rostral, middle, caudal) and POA, but because there were far fewer kisspeptin cells in the POA, the 
absolute number of Fos-expressing cells in this region was lower than in the ARC (Figure3). Examples of 
single- and dual-labeled kisspeptin neurons in the ARC and POA are shown in Figure 2C, and their 
anatomical location is shown in Figure 3.  The percentage of colocalization of kisspeptin with Fos did not 
differ between luteal and pre-surge animals in any area (Figure 2B).   
 
Experiment 2: which kisspeptin neurons respond to removal of E2 negative feedback? 
 As expected, LH pulse frequency increased after OVX from 1.0 ± 0.3 pulse/4 h in intact ewes to 2.0 ± 
0.3 pulses/4 h 1 d after OVX.  Frequency further increased to 4.0 ± 0.4 pulses/4 h in chronically OVX 
animals (Figure 4A).  Mean LH concentrations also increased three and nine fold in 1-d OVX and long-
term OVX ewes, respectively (Figure 4B).  
 In the ovary-intact anestrous ewes, ARC kisspeptin cells were most numerous in the caudal ARC, 
with moderate numbers present in the middle ARC and POA (Figure 5A). After more than 1 month after 
OVX, kisspeptin cell numbers significantly increased in both the rostral and middle ARC. A similar 
pattern of increased cell numbers was also observed in the 1-d post-OVX ewes (P< 0.05; Figure 5A). 
There were no significant effects of OVX on kisspeptin cell numbers in the POA.  
 E2 withdrawal significantly increased the percentage of ARC kisspeptin cells co-localizing Fos in the 
rostral, middle, and caudal ARC after 24 h post-OVX, and this colocalization was further increased in 
chronically OVX ewes  (P< 0.05; Figure 5B). No significant changes in the percentage of kisspeptin/Fos 
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colocalization were observed in the POA at either time point, and this percentage of colocalization 
remained low (<10%).   
Discussion 
Using a well-defined surge model, we observed that kisspeptin neurons of both the ARC and 
POA are activated after the onset of the preovulatory surge, indicating a role for both populations in E2-
positive feedback in the ewe. In contrast, we observed that ARC, but not POA, kisspeptin neurons are 
activated following the withdrawal of E2, suggesting that only ARC kisspeptin neurons are likely 
important mediators of E2-negative feedback.  
Several lines of evidence support the involvement of both ARC and POA kisspeptin neurons in 
E2-positive feedback in the ewe. First, in the late follicular phase, Kiss1 mRNA has been shown to 
increase in the middle and caudal ARC, as well as in the POA (10, 36).  Second, there was also an 
increase in kisspeptin protein in the ARC during this time (10).  Third, E2 treatment of OVX ewes 
increased kisspeptin mRNA and protein expression in the POA (35). Leading up to the surge, we 
observed an increase in kisspeptin cell number and fiber intensity in the middle ARC, which may reflect 
an increased sequestration of the peptide in the cell body as a result of the up-regulated Kiss1 mRNA (10, 
36). 
Although the aforementioned data show that Kiss1 mRNA and kisspeptin protein are up-regulated 
prior to the surge, our data show that soon after the onset of the preovulatory surge, kisspeptin cells are 
transcriptionally activated in both the ARC and POA. Interestingly, Smith et al. (10) failed to show an 
increase in Fos expression within POA kisspeptin cells 1 hr after a surge-inducing injection of E2 to OVX 
ewes. In their paper, they propose that the activation of these neurons may occur outside of the time 
window they chose to study (10), which could be consistent with our results. In contrast to the findings of 
Smith et al. (10), a recent study using ovary-intact ewes observed Fos expression in POA, but not ARC, 
kisspeptin neurons during the preovulatory LH surge (31). These authors suggested that the contrasting 
findings to previous work (10) might be due to different animal models (ovary-intact vs. OVX).  Our data 
confirm the activation of POA kisspeptin at the time of the LH surge reported by Hoffman et al. (31), but 
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we also observed increased Fos expression in the ARC population. One possible explanation for this 
discrepancy is that the chronic guide tubes traversing the ARC (used to monitor GnRH in the median 
eminence) in the animals used by Hoffman et al. (31) may have disrupted activation of ARC kisspeptin 
neurons. Another possible explanation is that different antibodies for detection of Fos were used in these 
two studies, suggesting the possibility that differences in observed Fos may be due to a different antibody 
sensitivity (Smith et al. used the same antibody we did).  Despite this discrepancy, most mRNA studies in 
the ewe are consistent with the idea that both ARC (KNDy) and POA kisspeptin neuronal populations 
participate in mediating E2 positive feedback in this species (10, 36). 
 In the second experiment, we observed a significant increase in both numbers of kisspeptin-
positive cells and their activation (as measured by Fos) in the ARC of long-term OVX ewes. Kisspeptin 
cell numbers and activation were also elevated, coincident with increased LH release, as early as 24 h 
post-OVX, demonstrating the rapid response of ARC kisspeptin neurons to the removal of E2. No changes 
were observed in the POA kisspeptin neurons at either time point. Thus we suggest that ARC, not POA, 
kisspeptin neurons mediate E2 negative feedback and therefore are likely key regulators of episodic LH 
secretion. These data confirm previous studies which found that chronic removal of E2 by OVX increased 
(22), and chronic E2-treatment decreased, both Kiss1 mRNA expression (10, 22) and number of 
kisspeptin-ir cells in the ovine ARC (10) during the breeding season. Our data extend these observations 
by demonstrating an early increase in both kisspeptin cell number and Fos colocalization following OVX. 
Similar to the work in sheep, studies in both humans and rodents also point to ARC kisspeptin neurons as 
mediators of E2 negative feedback. Postmenopausal women show both hypertrophy of kisspeptin neurons 
and increased kisspeptin gene expression in the infundibular nucleus (37), suggesting that kisspeptin in 
this area is normally held in check by steroid negative feedback. In rodents, OVX increases, and E2-
treatment decreases, Kiss1 expression in the ARC (26), but there is no evidence that OVX increases Fos 
expression in these neurons (38). 
In comparing kisspeptin populations involved in the positive and negative feedback actions of E2 
among species in which this question has been addressed, two consistent patterns emerge: 1) the more 
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rostral population (POA in sheep, AVPV and associated areas in rodents) is dedicated to the initiation of 
the LH surge, and 2) the ARC kisspeptin population participates in the negative feedback control of 
pulsatile LH secretion. In sheep, between 40 and 60% of POA kisspeptin neurons are activated during the 
surge (this study and (31)). This roughly corresponds with the ~50% of POA kisspeptin-ir neurons that 
express ERα (7), but whether this population overlaps with the activated kisspeptin cells observed here 
remains to be determined. These neurons may be stimulated directly by E2, but this seems unlikely 
because in the ewe the mediobasal hypothalamus, not the POA is the site at which E2 acts to induce an 
LH surge (39). Alternatively, these cells may be indirectly regulated, and subsequently activated, by 
steroid-sensitive afferents.  In rodents, E2 increases both kisspeptin expression (26) and Fos-colocalization 
with kisspeptin in the AVPV (24, 38, 40).  Interestingly, the percentage (ranging from 30-60%) of rostral 
kisspeptin neurons activated at the time of the surge in rodents (24, 38, 40) is similar to that in sheep. 
Almost all of these neurons in rodents contain ERα (26) and evidence suggests that E2 positive feedback 
in rodents occurs directly on these kisspeptin neurons (41). Studies that examined the more rostral 
kisspeptin population observed relatively low levels of kisspeptin/Fos colocalization in the absence of an 
LH surge in both sheep (10, 31) and rodents (24, 38, 40), again consistent with this population being 
dedicated to the LH surge. 
  It is also generally accepted that the ARC kisspeptin (KNDy) neurons in rodents and sheep 
mediate the negative feedback actions of E2. It has also been proposed that they drive episodic GnRH 
secretion (42-44), but there may be some species differences in their activation.  As already noted, OVX 
increased Fos expression in these neurons in sheep (this study), but apparently not in rodents (38). 
Moreover, in both current experiments, we observed that approximately 20% of KNDy neurons contain 
Fos during the follicular phase or during anestrous, even though LH secretion is at a basal level. This 
finding is apparently inconsistent with that of Hoffman et al. (31), who reported only about 5% of ARC 
kisspeptin neurons are activated in early follicular phase ewes (31). As discussed above, this may reflect 
differences in the antibodies used to detect Fos immunoreactivity or that Hoffman et al. (31) used tissue 
from ewes with chronic guide tubes traversing the ARC. Smith et al. (10) observed approximately 15% 
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ARC kisspeptin/Fos colocalization during the luteal phase of ewes, which increased to about 35% during 
the late follicular phase. The relatively high level of Fos expression in ovine KNDy neurons, compared 
with POA kisspeptin neurons, during basal secretion of LH is consistent with the hypothesis that KNDy 
neurons are important in tonic secretion of GnRH (42-44).  In contrast, colocalization of kisspeptin and 
Fos in the ARC of rats is less than 5% on diestrus 2 of the cycle (24). 
The one major difference between KNDy neurons in sheep and rodents is that they appear to 
participate in the LH surge in the former, but not the latter. Two of three studies observed high levels of 
Fos expression in KNDy neurons associated with the surge in sheep, whereas, with one exception (23), 
this has not been observed in rodents (24). As noted above, this difference is consistent with evidence that 
the positive feedback action of E2 occurs in the mediobasal hypothalamus in the sheep, and in the region 
of the AVPV in rodents (41). Interestingly, while almost all ovine KNDy neurons express ERα in the ewe 
(7), only 45-60% are activated during the surge. What remains unclear from these data is if this activation 
is due to heterogeneity in the ARC population, so that different subsets of neurons govern positive and 
negative feedback, or alternatively, if the same neurons govern positive and negative feedback, but are not 
activated at the same time. Moenter et al. (45), showed that approximately 40% of GnRH neurons were 
activated during the surge, and postulated that different neurons may be activated over time throughout 
the GnRH surge in order to maintain high levels of GnRH release. The high level of Fos expression in 
KNDy neurons of OVX ewes (70-90%, Figure 3.4) suggests that the same neurons are involved in both 
E2-positive and negative feedback. Reciprocal connections between KNDy neurons, that are postulated to 
play an important role in episodic GnRH secretion (42-44), may be responsible for the high percentage of 
activated KNDy neurons after OVX. If this is the case, the lower percentage of KNDy neurons containing 
Fos during the LH surge, may suggest a less important role for this reciprocal innervation.  This proposal 
is consistent with the changes in multi-unit electrical activity associated with LH pulses at the time of the 
LH surge in monkeys, rats and goats (46-48). Fos induction in most neurons is thought to be a 
consequence of glutamate release and its postsynaptic action, and it is interesting in this regard that a 
majority of KNDy neurons in the sheep colocalize glutamatergic markers (49), including expression 
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within terminals that form reciprocal KNDy-KNDy contacts (50).  Thus, release of glutamate from KNDy 
presynaptic terminals may be partly responsible for the Fos induction seen during increased pulsatile 
activity.   
 In summary, these data demonstrate that both the ARC (KNDy) and POA kisspeptin neurons are 
activated during, and therefore likely play an important role in, the GnRH/LH surge in ewes. In contrast, 
only ARC kisspeptin neurons had increased kisspeptin expression and activation following E2 removal, 
indicating the key role of ARC kisspeptin in the negative feedback regulation of episodic GnRH secretion 
by E2.   Whether the same or different subsets of ARC kisspeptin neurons are activated during surge and 
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Figure 1. Luteinizing hormone (LH) in luteal, pre-surge and surge ovary-intact ewes. A, 
Representative LH profiles from ovary-intact luteal, pre-surge and surge ewes taken before 
perfusion. Note that on the y-axis of the presurge and surge LH profiles, time = 0 represents 12 h 
after CIDR removal.  B, Mean LH levels at perfusion were significantly higher in the surge 
group compared with both luteal and presurge groups. Letters (a and b) represent significant 





























Figure 2. Kisspeptin cells in both the ARC and POA are activated during the LH surge.  
Kisspeptin cell number (A) and percent colocalization with Fos (B) in luteal, presurge and surge 
groups in the POA, and rostral, middle and caudal levels of the ARC.  Letters (a, b, and c) 
represent significant differences between groups within the same area, P < 0.05.  C, Sections 
immunestained for kisspeptin and Fos through the middle ARC (left column) and POA (right 
column) from luteal, pre-surge and surge animals. Arrows show examples of dual-labeled cells. 




















Figure 3. Camera lucida drawings of representative sections through the POA (top) and ARC 
(bottom) of sheep killed either during the LH surge (left) or 30 d after OVX (right). The location 
of single-labeled kisspeptin cells (open circles) and dual-labeled Fos/kisspeptin cells (black 
circles) are shown at low and high magnification in each of the drawings (boxed areas). ac, 
anterior commissure; 3V, third ventricle; fx, fornix; oc, optic chiasm; ot, optic tract; mt, 















Figure 4. Luteinizing hormone (LH) in intact and OVX ewes. A, Representative LH profiles 
from ovary-intact, 1 d after OVX, and more than 30 d post-OVX ewes. Black circles indicate 
pulse peaks. Note different scale on y-axis for data from ewe OVX for more than 30 d. B, Mean 
pulse frequency (top panel) and LH concentration (bottom panel) in each group of ewes. Letters 

























Figure 5. Ovariectomy increases activation of kisspeptin cells in the ARC, but not the POA.  
Kisspeptin cell number (A) and percent colocalization with Fos (B) in ovary-intact, 1 d post-
OVX, and more than 30 days post-OVX ewes in the POA and rostral, middle, and caudal 
sections of the ARC. Letters (a, b, and c) represent significant differences from each  other 
within the same area, P < 0.05. C, Sections immunostained for kisspeptin and Fos through the 
middle ARC in gonadal-intact and long-term (> 30 d) OVX ewes. Arrowhead and arrows 
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  Neurokinin B (NKB) is essential for human reproduction and has been shown to stimulate LH 
secretion in non-rodent species, including sheep. Ewes highly express the neurokinin-3 receptor (NK3R) 
in the retrochiasmatic area (RCh) and placement of senktide, an NK3R agonist, therein stimulates LH 
secretion that resembles an LH surge in ewes. In this study, we investigated the effects of the natural 
ligand, NKB, or senktide in the RCh and three other areas where NK3R is found in high abundance: the 
preoptic area (POA), paraventricular nucleus (PVN), and arcuate nucleus (ARC). Bilateral microimplants 
containing NKB had no effect on LH secretion when given in any of the four areas, while senktide-
containing microimplants induced a dramatic surge-like increase in LH when given in the RCh and POA.  
A relatively smaller, but significant, increase after senktide treatment was observed in the ARC. No effect 
was seen in the PVN. The possible role of POA and RCh NK3R activation in the LH surge was then 
tested by treating ewes with SB222200, an NK3R antagonist, in each area during an E2-induced LH 
surge. SB222200 in the RCh, but not in the POA, reduced LH surge amplitude compared to controls, 
indicating that NK3R activation in this region is essential for full expression of the preovulatory LH 
surge. Based on these data, we suggest that NKB actions in the RCh are an important component of the 














 Although more than twenty years have passed since the initial study linking NKB to LH secretion 
in humans (1) and more recent evidence clearly demonstrated that NKB is critical for reproduction in 
humans (2), the details of how and where NKB acts to influence LH release remain largely unknown. 
Most work on NKB has focused on its possible roles in controlling tonic, episodic LH secretion.  Low 
levels of tonic secretion of GnRH/LH are maintained during the luteal phase and early follicular phase by 
the negative feedback actions of estradiol (E2) and progesterone (3). However, these feedback actions of 
ovarian steroids on GnRH are likely indirect since GnRH neurons do not express progesterone receptors 
(PR) (4,5) or ERα (6), the ER isoform responsible for regulating GnRH secretion (7). NKB neurons may 
participate in steroid negative feedback regulation of GnRH release because they highly express ERα (8). 
 Interest in NKB as a regulator of GnRH release began with the discovery that a subset of neurons 
coexpressing NKB and ERα in the infundibular nucleus undergo hypertrophy in postmenopausal women, 
indicating that NKB is under E2-negative feedback control (1). These investigators further postulated that 
this hypertrophy was indicative of increased activity and thus NKB may contribute to the menopause-
associated increase in LH release. Subsequent studies confirmed that E2 inhibits NKB as removal of 
steroid negative feedback via ovariectomy (OVX) increased NKB gene expression in the ARC of female 
monkeys (9,10), sheep (11), rats (12), and mice (13,14), while E2 treatment of OVX animals suppressed 
NKB gene expression in these same species (10,12,14-17). Furthermore, stimulation of LH secretion by 
NKB or senktide, a neurokinin-3 receptor (NK3R) agonist, has been described in non-rodent species 
including adult sheep (18,19), prepubertal ewes (11), and prepubertal male monkeys (20). In rodents, the 
effects of NKB or senktide on GnRH/LH secretion appear to be dependent on steroid milieu (21). Data 
consistently shows that NK3R agonists stimulate LH secretion in gonad-intact mice (22,23) and rats 
(21,24), but that they inhibit LH secretion in OVX mice (14) and rats (21,24). However the effects of 
NK3R agonists in OVX + E2 rodents lack consistency, with either inhibition or stimulation of LH release 
in rats (21,24,25) and no effect in mice (14). 
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 While NKB is clearly an important regulator of LH secretion, it is unclear where NKB 
specifically acts to control GnRH release. The discovery that most ARC NKB neurons in ewes coexpress 
kisspeptin and dynorphin (thus named KNDy neurons) suggests that NKB closely interacts with 
kisspeptin (26), which is a potent stimulator of GnRH/LH secretion (27). More recently, NK3R was 
found to colocalize with a majority of NKB neurons in rats (28), mice (14), and sheep (29), while few or 
no GnRH neurons were found to express NK3R in rats (21) and sheep (29), respectively. In contrast, the 
vast majority of GnRH neurons express the kisspeptin receptor, Kiss1r in both rodents (30,31) and sheep 
(32), indicating that kisspeptin, but not NKB, directly affects GnRH neurons. These data, as well as 
others, have led to the hypothesis that NKB, acting via kisspeptin, is responsible for driving episodic LH 
secretion via a reciprocal KNDy neuron network while dynorphin acts as a brake to this system 
(14,33,34).  
 Although most NKB studies to date have focused on control of tonic GnRH secretion, this 
peptide may also be involved in the GnRH/LH surge. Both injection of senktide in the third ventricle and 
placement of senktide-containing microimplants in the retrochiasmatic area (RCh) of the hypothalamus 
significantly stimulate LH secretion in ewes, with the high LH levels and pattern of secretion more 
closely resembling an LH surge than tonic LH secretion (18). However, it is unclear whether NK3R 
agonists have similar effects in other areas of the hypothalamus or if endogenous NKB plays a role in the 
LH surge. Therefore, the aim of our first study was to determine in which hypothalamic areas NKB or the 
NK3R agonist, senktide, acts to stimulate LH secretion. NK3Rs are highly expressed in the ovine preoptic 
area (POA), paraventricular nucleus (PVN), RCh, and ARC (29). The aim of our second study was to 
determine whether activation of NK3R in senktide-responsive areas is necessary for a normal LH surge.  
METHODS 
Animals. All experiments used adult ewes of predominantly Suffolk breeding that were housed indoors 
under a controlled photoperiod simulating natural outdoor day length. Ewes were fed a pelleted alfalfa 
diet and provided free access to water and supplemental minerals. Breeding season experiments were 
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performed from October to mid-February and anestrus experiments from May through August. For 
experiments in follicular phase ewes (Exps. 1 and 3), ovarian cycles were synchronized as previously 
described (18). Briefly, two intramuscular (im) injections of prostaglandin F2α (5 mg/mL, Luteolyse, 
Pharmacia & Upjohn Co., NY, NY) were given 3 h apart, and this regimen was repeated seven days later. 
At this time two progesterone-containing controlled internal drug-releasing devices (CIDRs; Eazi-Breed, 
Pharmacia & Upjohn, New York, NY) were inserted intravaginally to produce luteal phase levels of 
progesterone. Seven days later PGF2α was again injected and CIDRs were removed. Experiments began 
18 h later, during the early follicular phase. All procedures were approved by the West Virginia 
University Animal Care and Use Committee and conducted in accordance with NIH guidelines on the 
care and use of animals in research. 
Surgeries. All surgeries were performed under sterile conditions using isofluorane anesthesia. Ewes were 
first anesthetized using a combination of ketamine and diazapem injected IV to facilitate insertion of a 
tracheal tube. Bilateral chronic 18-gauge guide cannulae were stereotaxically inserted into either the RCh, 
POA, PVN or ARC as previously described (35). Ovariectomies were performed via midventral 
laparotomy (36). Ewes were treated with dexamethasone and penicillin pre- and post-operatively, and 
daily with analgesic (Banamine, Phoenix Pharmaceutical, St. Joseph, MO; 125 mg/sheep) starting at the 
time of anesthesia to 5 days after surgery. 
Experimental Approach. To determine whether the natural ligand NKB, the NK3R agonist senktide, or 
the NK3R antagonist SB222200 (all obtained from Tocris Bioscience, Ellisville, MO) altered LH 
secretion, we administered the drugs by microimplantation or microinjection into the RCh, POA, PVN, or 
ARC. Microimplants were constructed from 22-gauge stainless steel tubing and cut to extend to the tip of 
the guide cannulae for ARC experiments or 1.5 mm beyond the tip for the RCh, PVN, and POA. Our 
previous work showed that extending empty microimplants beyond the end of the guide tube within the 
ARC influenced LH release (37). Microimplants were filled by tamping 40 times in crystalline NKB, 
senktide, or SB222200. As a control, empty microimplants were used. For microinjections, needles were 
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adjusted to a length that extended 1.5 mm beyond the tip of the guide cannulae.  Senktide (10 pmol/300 
nL sterile water) or sterile water alone was injected.  
Experiment 1A: Effect of NKB microimplants in the RCh, POA, PVN, or ARC on LH release in 
follicular phase ewes. Starting 18 h after CIDR removal, blood samples were collected by jugular 
venipuncture every 12 min for 24 min before and for 4 h after insertion of NKB-filled or empty 
microimplants.  Samples were then taken every 30 min for an additional 4 h, after which microimplants 
were removed, obturators replaced to occlude the guide cannulae, and two CIDRs inserted intravaginally.  
Seven days later, CIDRs were removed, PGF2α was injected, and the treatment protocol repeated using a 
cross-over design so that ewes given NKB in the first replicate received empty microimplants during the 
second and vice versa.  
Experiment 1B: Effect of senktide microinjection in the POA or PVN on LH release in follicular phase 
ewes. Because NKB was ineffective in Exp. 1A, we next tested whether senktide would act in the POA or 
PVN to increase LH secretion using these same animals; stimulation of LH release by local 
administration of senktide to the RCh and ARC had already been demonstrated in our earlier work 
(18,37). Ovarian cycles were synchronized as described above and experiments were performed during 
the early follicular phase. Frequent blood samples (every 10 min) were collected from each ewe before 
and after bilateral microinjections (within 2 min of each other) of vehicle or senktide (10 pmoles/side); 
treatments were randomized with 1 h of sampling between injections when vehicle was injected first, and 
4 h between injections when senktide was given first. An increase in LH concentrations in response to 
senktide was determined by comparing the mean of the three samples following injection of senktide vs. 
vehicle.  
Experiment 2: Effect of NKB or senktide in the RCh of anestrous ewes. The failure of NKB to stimulate 
LH secretion when placed within the RCh in Exp. 1 raised the possibility that actions of NKB and 
senktide might differ since our previous work showed that microimplants of senktide in the RCh 
stimulated LH secretion in follicular phase ewes (18). Therefore, we next directly compared the effects of 
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these two NK3R agonists in the RCh of ovary-intact anestrous ewes. Anestrous ewes were previously 
shown to respond to RCh senktide treatment in a manner similar to follicular phase animals (18). Because 
the ewes were anovulatory, synchronization of ovarian cycles was not needed. Blood collection and 
treatment protocols were conducted as described in Experiment 1, except that three treatments were 
given: empty, NKB-containing, or senktide-containing microimplants administered in a random order, 
with 8 d between treatments.  
Experiment 3: Effect of senktide microimplants in the POA and ARC on LH release in follicular phase 
ewes. The protocol was the same as that used for Experiment 1, except that senktide-containing 
microimplants were used in place of NKB-containing microimplants and only the POA and ARC were 
targeted.  
Experiment 4: Effect of SB222200 in the RCh or POA on the E2-induced LH surge. Ewes underwent 
OVX in addition to neurosurgery for guide cannulae placement aimed at the RCh (in September) or POA 
(in January). At the time of OVX, one short (1 cm) E2-containing Silastic implant was inserted 
subcutaneously (s.c.) and two CIDRs were inserted intravaginally. CIDRs were removed 10-14 days later. 
Twenty-four hours post-CIDR removal, four long (3 cm) E2-containing Silastic implants were inserted 
s.c., to establish an artificial follicular phase and produce an LH surge (38). Either empty or SB222200-
containing microimplants were inserted into the RCh or POA just before insertion of the long E2 implants.  
Starting 8 h later, jugular blood samples were taken every 2 h for 24 h then continued every 4 h for an 
additional 12 h. New SB222200-containing microimplants were inserted 24 h after original microimplants 
were inserted to maintain SB222200 delivery. At the conclusion of the sampling period, microimplants 
and the longer E2 implants were removed. SB222200 powder was still visible in the lumen of the 
microimplants at removal. CIDRs were reinserted 3 days later to reestablish an artificial luteal phase. Ten 
days after CIDR insertion, CIDRs were removed and the experiment was repeated in crossover design so 
that each ewe received both control and SB222200 treatment. 
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Tissue collection. One or two days after conclusion of the final blood sampling period in all experiments, 
ewes were euthanized via an overdose of sodium pentobarbital (8-12 ml of Euthasol; 390 mg 
pentobarbital sodium/mL; Webster Veterinary, Devens MA). Two iv injections of heparin (25,000 U) 
were given 10 minutes prior to, and immediately before, pentobarbital. The head was quickly removed 
and perfused via the carotid arteries with 6 liters of 4% paraformaldehyde in 0.1 M phosphate buffer 
containing 0.1% NaNO3. After perfusion, a block of tissue containing the POA and hypothalamus was 
dissected from the brain and stored in paraformaldehyde overnight at 4 C. The tissue was then infiltrated 
with 30% sucrose, and coronal sections (50 μm thick) were cut on a freezing microtome and stored at -20 
C in cryoprotectant. A series of every fifth section was mounted on slides and stained with cresyl violet to 
evaluate cannulae placement. 
Assays. Using an RIA which has previously been validated in sheep (39), LH was measured in duplicate 
using 25-200 μl of plasma and expressed in terms of NIH-LH-S12. The minimal detectable concentration 
of LH in these assays averaged 0.10 ng/tube; intra- and interassay coefficients of variation were 15.0% 
and 18.2%, respectively. To confirm stage of the estrous cycle in ovary intact ewes, circulating 
progesterone was measured in duplicate aliquots of 150 μl plasma using a commercially available solid-
phase RIA kit (Coat-A-Count Kit, Diagnostics Products Corporation, Los Angeles, CA), which has been 
validated in sheep (35). All follicular-phase ewes had plasma progesterone concentrations less than 0.3 
ng/ml; intra- and interassay coefficients of variation were 2.3% and 1.2%, respectively. 
Statistical analysis. LH pulses were identified using established criteria (3,40) for samples collected 
during the first 4 h of treatment in Exps. 1-3. Comparisons of LH pulse frequencies in these three 
experiments were accomplished using a Wilcoxin-Mann-Whitney test. Differences in mean LH 
concentrations (all samples), LH pulse amplitude (peak minus previous nadir), and pulse nadir (lowest 
value preceding each pulse) were analyzed by the Holm-Sidak one-way repeated measures ANOVA and 
post hoc analyses of pair-wise comparisons were completed using paired t-tests. Data are reported as 




Experiment 1A: Effect of NKB microimplants in the RCh, POA, PVN, or ARC on LH release in 
follicular phase ewes. Most ewes in each group had correctly placed guide cannulae (5 of 6 in the RCh, 5 
of 6 in the POA, 3 of 4 in the PVN, and 4 of 5 in the ARC). We consistently observed no significant 
effect of NKB microimplantation on LH secretion in any of these areas (Fig. 1). Low amplitude LH 
pulses were observed in all ewes and neither LH pulse amplitude nor frequency was altered by treatment 
in any area (data not shown).  
Experiment 1B: Effect of a senktide microinjection in the POA or PVN on LH release in follicular 
phase ewes. A single microinjection of senktide significantly stimulated LH secretion in the POA 
compared to saline (2.15 ± 0.38 vs. 1.34 ± 0.26 ng/mL, respectively), but not in the PVN (1.87 ± 0.40 vs. 
1.86 ± 0.27, respectively).  On average, peak LH concentrations were observed 36 min following senktide 
injection and values returned to nadir within 1 h.  
Experiment 2: Effect of NKB vs. senktide treatment in the RCh on LH secretion in anestrous ewes. 
Five of the seven ewes had correctly placed microimplant sites in the RCh (Fig. 2A). They were within 
0.5-1.5 mm of the base of the brain and at the posterior end of the optic chiasm (Fig. 2A, left panel). 
Placement in two ewes was too posterior (Fig. 2A, right panel). The five ewes with appropriate 
placements responded to senktide microimplants with a significant and sustained increase in LH secretion 
(Fig. 2B), a response similar to that which we previously reported (18). LH concentrations peaked at 16.9 
± 3.4 ng/mL 3 h after microimplant insertion and remained significantly elevated for a total of 4.5 h. The 
observed elevation in LH secretion was continuous, and pulses were undetectable during this period of 
elevated secretion.  The two ewes with misplaced cannulae had a much lower LH peak (~3.5 ng/mL), 
which was not significantly different than peak control values. In contrast to the effects of senktide, none 
of the ewes showed an increase in LH secretion during NKB treatment (Fig. 2B). Low frequency LH 
pulses were observed during treatment with either NKB or empty microimplants, and no changes in LH 
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pulse frequency were observed (1.4 ± 0.3 pulses and 1.4 ± 0.4  pulses in a 4 h period in controls and in 
NKB-treated groups, respectively).  
Experiment 3: Effect of senktide microimplants in the POA or ARC on LH secretion in follicular 
phase ewes. Five of six ewes had correct microimplant placements in the POA (Fig. 3A, light grey 
circles; Note: The white circles in Fig. 3A and 3B depict placement of guide cannuluae in ewes from Exp. 
1 that received NKB treatment and illustrate similar placement in the two experiments). Insertion of 
empty microimplants had no obvious effects on LH secretion. All five ewes with correct cannulae 
placement responded to senktide microimplants with a sustained increase in LH secretion, the average 
peak being 22.4 ± 9.1 ng/mL (Fig. 3C). The rise in LH was first significant 2 h after microimplant 
insertion and remained significantly elevated throughout the sampling period. The observed elevation in 
LH secretion was continuous, and pulses were undetectable during this period of elevated secretion. The 
ewe with cannulae placement posterior to the POA had a lower maximum LH level of ~2.8 ng/mL, 
similar to that seen with control treatment.  
 Four of six ewes had correctly placed microimplant sites in the ARC (Fig. 3B, light grey circles); 
in each of the other 2 ewes, one guide cannula was placed within the third ventricle. All four ewes with 
correct cannulae placement responded to senktide microimplants with an increase in LH secretion as 
compared to empty implants (Fig. 3D).  However, the average peak LH secretion (5.8 ± 2.5 ng/mL) was 
significantly lower than that observed in the POA group. Senktide treatment did not alter LH pulse 
amplitude, but decreased LH pulse frequency compared to controls (0.4 ± 0.1 pulse/h vs. 0.8 ± 0.1 
pulse/h, respectively), and increased the mean nadir values (4.53 ± 1.53 ng/mL vs. 0.98 ± 0.20 ng/mL, 
respectively). Each of the two ewes with one of the guide cannulae in the third ventricle had much higher 
peak LH values, averaging 52.2 ng/mL.  
Experiment 4: Effect of SB222200 in the RCh or POA on the E2-induced LH surge.  Four of the five 
ewes in the RCh group had correct placement of guide cannulae (data not shown), while the end of the 
guide tubes rested within the optic chiasm of the fifth ewe. LH surges are shown for two representative 
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ewes with guide cannulae targeting the RCh in Fig. 4A. LH surges occurred in all five ewes, regardless of 
treatment, with peak LH release after insertion of the four E2 implants occurring at 24.5 ± 2.6 h in controls 
and 27.7 ± 2.8 h in SB222200-treated ewes (P > 0.05). All four ewes with correct placement of cannulae 
exhibited blunted LH surge amplitudes when treated with SB222200 in the RCh so that mean amplitude 
was significantly less compared to that during treatment with empty microimplants (108.4 ± 17.5 vs. 
185.1 ± 10.2 ng/mL, respectively; Fig. 4B). In the ewe with missed cannulae placement, LH surge peak 
amplitude was higher during SB222200 treatment than during control treatment (232.2 ng/mL vs. 132.2 
ng/mL, respectively). 
 All six ewes in the POA group had accurate guide cannulae placement and all exhibited E2-
induced LH surges regardless of treatment, with peak LH values post-E2 treatment occurring at 23.6 ± 1.0 
h in controls and at 25.0 ± 0.9 h in SB222200-treated ewes, which did not differ significantly. Average 
peak LH levels were not different between treatments (Fig. 4C). Amplitudes of LH surges during 
treatment with empty implants were noticeably higher in ewes of the RCh group compared to those in the 
POA group. This difference is likely due to the fact that the RCh work was carried out in the middle of 
the breeding season whereas the POA experiment was performed near the end of the breeding season.  
Previous work has shown that LH surge amplitude using this surge-inducing paradigm is greater earlier in 
the breeding season than later (41).  
DISCUSSION 
 The presence of NK3R and kisspeptin in KNDy neurons has led to the hypothesis that NKB 
elicits LH release by autocrine or paracrine actions on ARC KNDy neurons to cause kisspeptin release 
which in turn stimulates GnRH release.  However, NK3R expression is also relatively high in other areas 
of the hypothalamus (POA, PVN, and RCh). This raises the possibility that NKB may also act in these 
other areas to influence GnRH/LH release.  We found that senktide stimulated surge-like LH secretion 
when administered within the ovine RCh or POA but produced a more modest increase in the ARC and 
had no effect in the PVN. These results point to both the POA and RCh as possible sites for NKB 
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stimulation during the GnRH/LH surge, but only blockade of the NK3R in the RCh reduced LH surge 
amplitude. This confirms and extends previous data from our laboratory that demonstrated stimulatory 
effects of senktide in the RCh (18). In contrast, we did not find any significant effect of NKB on LH 
secretion when placed in the POA, RCh, ARC or PVN. 
 The increase in LH release following administration of senktide in the RCh and POA resembled 
surge-like LH secretion, suggesting that NKB may be involved in the GnRH/LH surge, a hypothesis that 
until now has not been directly tested. However, the sex-specific nature of the GnRH/LH surge and NKB 
gene and protein expression is consistent with the proposal that NKB may be involved in the GnRH/LH 
surge. Female sheep have relatively high numbers of NKB-immunoreactive cells or levels of NKB gene 
expression and the capability of exhibiting LH surges while males or androgenized females express 
significantly less NKB and fail to exhibit an E2-induced LH surge (8,42).  
 Although a number of studies have demonstrated stimulatory effects of NK3R agonists on LH 
secretion, this is the first to show, using a receptor antagonist, that NK3R activation is essential for the 
full LH surge. This effect seemed specific to the RCh as SB222200 placed in the POA, or in the one RCh 
ewe with misplaced guide cannulae, did not alter the E2-induced LH surge. In contrast, senktide treatment 
in both areas stimulated surge-like LH secretion. While the lack of effect of SB222200 would appear to 
rule out a role for POA NK3R in the endogenous GnRH surge, it is important to note that neurons 
expressing NK3R in the POA are more widely scattered than NK3R-positive neurons in the RCh (29). 
This difference provides a possible alternative explanation for these data. Senktide, which is highly 
soluble in water, may have diffused far enough to reach sufficient receptors in both areas to stimulate 
surge-like LH release, while SB222200, which is relatively insoluble in water, may not have reached 
enough NK3R-positive cells in the POA to affect the LH surge, but did so when placed in the RCh. 
  The identity of neurons in the RCh that express NK3R is unknown, but they do not appear to be 
the A15 population of dopamine neurons (18) that are prominently involved in seasonal breeding (43,44). 
Likewise, the pathway through which activation of RCh NK3R acts to stimulate LH secretion is yet to be 
identified, but may well involve kisspeptin neurons. The importance of kisspeptin in the LH surge has 
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previously been demonstrated with intracerebroventricular administration of a Kiss1r antagonist 
suppressing the LH surge amplitude by ~50% in ewes (32). Our data showing a similar degree of 
suppression (42%) of the LH surge raise the possibility that the NK3R antagonist is blocking the same 
neural pathway as the Kiss1r antagonist in that study. Neither SB222200 treatment nor the Kiss1r 
antagonist (32) alters the timing of the surge, which may indicate that NKB and kisspeptin act only to 
ensure the full expression of the LH surge, but do not act to initiate the surge.  
We cannot rule out the possibility that the incomplete blockage of the LH surge is a result of the 
SB222200 treatment not fully blocking all NK3R in the RCh. Moreover, NK3R in multiple areas (other 
than just RCh) may need to be blocked in order to completely prevent the LH surge because several 
hypothalamic areas appear to participate in the LH surge in ewes.  For example, in addition to the RCh, 
the POA and MBH are involved because Fos expression in kisspeptin (45) and GnRH (46) neurons in 
both the POA and MBH is increased at the time of surge. 
 Unexpectedly, we found that NKB was ineffective in influencing LH secretion whereas senktide 
clearly increased in LH release. We would put forward two possible explanations for this discrepancy. 
The first is based on possible differences in the bioavailability of senktide and NKB. Senktide, but not 
NKB, is highly soluble in aqueous solutions. Thus, it is possible that senktide diffused much further than 
NKB, giving it the opportunity to interact with more NK3R at higher concentrations. Senktide may also 
be metabolized more slowly than NKB because it is a synthetic peptide, further increasing its ability to 
interact with receptors for a longer period of time than NKB. The second possible explanation is based on 
the varying receptor selectivity of NKB and senktide. Senktide is highly selective for the NK3 isoform 
(47), while NKB can bind to all three subtypes (NK1R, NK2R, and NK3R), albeit having the highest 
binding affinity for NK3R. Interaction with other receptor subtypes could account for the ineffectiveness 
of NKB if either of the other receptor types is inhibitory to LH secretion in ewes. There is evidence that 
activation of NK2R by neuropeptide K (NPK) or activation of NK1R by substance P can inhibit LH 
secretion in female rats (48,49), although stimulatory effects of these agonists have also been observed 
(50). It was also recently reported that ex vivo NKB stimulation of murine ARC kisspeptin neurons was 
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blocked only by applying a cocktail of NK1R, NK2R, and NK3R antagonists, but not by the application 
of an NK3R antagonist alone (51). These findings suggest that NKB can activate multiple tachykinin 
receptor subtypes in KNDy neurons. It should be noted, however, that this explanation for the different 
effects of senktide and NKB requires the expression of these NKB receptor subtypes in the same areas in 
the ovine hypothalamus, but at this time there is no evidence regarding the distribution of NK1R or 
NK2R expression in sheep.   
 Although we cannot rule out the possibility that higher doses of senktide would be effective, the 
observation that senktide microinjection in the PVN does not alter LH concentration suggests that NK3R 
in this region may be involved in other effects of NKB, such as regulation of vasopressin release (50). In 
contrast, the significant but small LH response to ARC senktide treatment indicates that ARC NK3R are 
likely not involved in LH surge regulation. Surprisingly here, senktide microimplants in the ARC 
decreased LH pulse frequency while it is previously reported that NKB microimplants in this area 
consistently increased LH pulse frequency in OVX ewes (37). The observed decrease in pulse frequency 
may reflect the increase in LH concentrations we noted between pulses, making pulse identification 
difficult. A similar effect of senktide has also been noted in OVX ewes (52). In any case, the relatively 
modest increase in mean LH concentrations (compared to senktide effects in the RCh and POA) may 
indicate a role for ARC NKB signaling in governing tonic LH secretion. This is consistent with previous 
data implicating KNDy neurons in the control of episodic GnRH secretion (33). 
 While these data indicate that NKB contributes to the LH surge in sheep, it is unlikely to play a 
similar role in rats because a Kiss1r antagonist completely blocked the surge in this species (53). In 
agreement with the lack of NKB involvement in the rodent surge, several lines of data indicate that the 
positive feedback action of E2 in rodents is mediated by AVPV kisspeptin neurons (54-56). In contrast E2 
acts in the MBH of sheep to induce the LH surge (57), so it is not surprising that different neural systems 
are involved in these species. Since E2 also acts in the MBH to induce the LH surge in primates (58), we 
suggest that the role NK3R in sheep may be similar to that in non-human primates and humans. This 
possibility is consistent with the genetic data indicating that NKB/NK3R interaction is essential for 
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reproduction in humans (2). In contrast, NK3R knockout mice remain fertile (59), albeit with some 
deficits in reproductive function (60). This indicates that NKB is not necessary for ovulatory cycles in 
mice, but does appear to be critical in sheep and humans. 
 In summary, we show herein that administration of the NK3R agonist senktide in either the POA 
or RCh stimulates surge-like LH secretion and that blockade of the NK3R in the RCh attenuates the 
amplitude of the LH surge. The mechanisms underlying the effectiveness of senktide, but ineffectiveness 
of NKB, in eliciting surge-like LH secretion are unclear, but may be explained in part by participation of 
other NKB receptor isoforms. While the area of the ARC in the sheep is believed to be where E2 acts to 
induce a GnRH/LH surge, the neural mechanisms involved are much less understood. Based on these data 
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Figure 1. LH (± SEM) concentrations during treatment with NKB-containing (shaded squares) or empty 
(open circles) microimplants in the RCh (n=5), POA (n=5), PVN (n=3), and ARC (n=4) of ewes during 
the early follicular phase. No significant differences in mean LH values or pulse frequency were 
























































Figure 2. Top panel (A) depicts microimplant placement within the RCh in ewes used in Exp. 2. Bottom 
panel (B) depicts LH concentrations during treatment with NKB-containing (shaded squares), senktide-
containing (shaded triangles) or empty microimplants (open circles) in the RCh of intact anestrous ewes 
(n=5). Values represent the mean (± SEM) LH concentration from all ewes in each group, at each time 
point. The grey bar indicates the time period of microimplant treatment. The asterisk indicates the first 
point at which LH concentration in senktide-treated ewes was greater compared to controls. No difference 






























Figure 3. Top panel depicts microimplant placement within the POA (A) and ARC (B) in ewes used in 
Exp. 3 (grey circles) and ewes from Exp. 1 (treated with NKB; white circles). The bottom panel depicts 
the mean (± SEM) LH concentrations during treatment with senktide-containing (shaded triangles) or 
empty (open circles) microimplants in the POA (C; n=5) or ARC (D; n=4) in, early follicular phase ewes. 
Grey bars indicate the time period of microimplant treatment. Asterisks indicate the first point at which 










































Figure 4. The top panel (A) depicts LH profiles from two representative ewes from the RCh group with or 
without SB222200 treatment during an E2-induced LH surge. The middle panel (B) shows the mean (± 
SEM) LH concentrations from all ewes (n=4) at each time point surrounding the LH surge with 
SB222200-containing (grey circles) or empty (open circles) microimplants in the RCh. The asterisk 
indicates that the LH surge amplitude in the presence of SB222200 was significantly lower (P < 0.05) 
than the amplitude observed with empty microimplants. The bottom panel (C) shows the mean (± SEM) 
LH concentration from all ewes (n=6) treated with SB222200-containing (grey circles) or empty (open 
circles) microimplants in the POA during an E2-induced surge. No differences in surge amplitude were 
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 The NK3R agonist, senktide, is a potent stimulator of LH release in non-rodent species, including 
sheep. Specifically, in ewes, senktide placed within the retrochiasmatic area of the hypothalamus (RCh) 
or preoptic area (POA) elicited surge-like LH secretion and administration of an NK3R-antagonist within 
the RCh significantly reduced the amplitude of an E2-induced LH surge. Together, these findings suggest 
that NKB acts within these areas to regulate the preovulatory LH surge. However, the pathway through 
which NK3R activation in these areas stimulates GnRH/LH secretion remains unclear. Several studies 
suggest that NKB may act by eliciting kisspeptin release from KNDy (kisspeptin/neurokinin 
B/dynorphin) neurons, which have been shown to project directly to GnRH neurons. The aim of these 
studies was to determine if senktide-induced stimulation of LH release in ewes after placement within the 
RCh or POA involves kisspeptin release from KNDy neurons. Senktide microimplants in the RCh or 
POA increased the percentage of KNDy neurons that were active, as assessed by cFos colocalization, 
compared to empty implants, but did not alter activation of POA kisspeptin neurons. 
Intracerebroventricular infusion of a Kiss1r antagonist blocked the RCh senktide-induced LH secretion in 
some ewes, but failed to do so in others.  Thus, the effects of senktide may be kisspeptin-dependent, but 
further work will be needed to determine the relative importance of kisspeptin, and more specifically 













 Neurokinin B (NKB) and kisspeptin have been the subject of intense focus recently, as they have 
both been identified as essential components of reproduction in humans (1-3). They clearly play an 
integral role in regulating GnRH and LH secretion in rodents (4-7), sheep (8-11), and primates (12;13). 
However, the manner in which these peptides, either separately or together, act to regulate GnRH release 
is unclear. 
 NKB and kisspeptin, along with dynorphin A, are coexpressed in a population of neurons located 
within the arcuate nucleus and thus have been termed KNDy neurons (14).  At least in sheep and goats, 
KNDy neurons are thought to be a vital component of the LH pulse generator due to the following 
evidence: 1) KNDy neurons form an unusual reciprocal network, in which projections from KNDy 
neurons synapse on other KNDy neurons, perhaps enabling them to fire synchronously (15), 2) electrical 
recordings from the posterior ARC (where most kisspeptin neurons are located) in goats reveal pulsatile 
bursts of multi-unit activity from neurons in this area in association with LH pulses (16), and 3) KNDy 
neurons project to, and synapse on, GnRH neurons in the preoptic area (POA) as well as the mediobasal 
hypothalamus (MBH) (14). Furthermore, KNDy neurons express the primary NKB receptor (NK3R), but 
not the receptor for kisspeptin (Kiss1r). Virtually all GnRH neurons express Kiss1r, but not NK3R, laying 
the foundation for the hypothesis that NKB serves to stimulate kisspeptin release and thus the onset of a 
GnRH pulse, while dynorphin acts to terminate kisspeptin output and the GnRH pulse (14).   
 To date, essentially all studies on NKB have been focused on its putative role in GnRH pulse 
generation. However, we recently demonstrated in ewes that senktide treatment in the retrochiasmatic 
area (RCh) or the POA, both areas which highly express NK3R (17), stimulates surge-like LH secretion, 
indicating that NKB-NK3R signaling may also play a role in the LH surge (see Chapter 3). In addition, 
we found that NK3R activation in the RCh is necessary for the full LH surge in ewes, as an antagonist to 
NK3R blunted LH surge amplitude by ~42% (see Chapter 3). However, the neural pathway through 
which activation of NK3R outside of the arcuate nucleus (ARC) alters LH secretion is unclear. Since 
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blockade of Kiss1r has previously been shown to cause a similar decrease in LH surge amplitude (11) and 
because KNDy neurons and POA kisspeptin neurons exhibit increased activation during the preovulatory 
LH surge (18), we tested the hypothesis that NK3R-positive neurons in the RCh or POA act via KNDy 
neurons and/or POA kisspeptin neurons to stimulate GnRH/LH secretion.  In the first study, senktide was 
targeted to the RCh or POA and activation of KNDy or POA kisspeptin neurons assessed by cFos 
colocalization.  The ability of senktide placed in the RCh to stimulate surge-like LH secretion in the 
presence of a Kiss1r antagonist was also assessed. 
METHODS 
Animals 
Adult ewes of predominantly Suffolk breeding, housed indoors under a controlled photoperiod 
simulating natural outdoor day length were used for all experiments. Ewes were fed a pelleted alfalfa diet 
and provided free access to water and supplemental minerals. Experiments using anestrous ewes were 
performed from May to August, and experiments performed during the breeding season were done from 
October to February. Additionally, estrous cycles in ewes used for follicular phase experiments performed 
in the POA were synchronized as reported previously (8). Briefly, two intramuscular (im) injections of 
prostaglandin F2α (5 mg/mL, Luteolyse, Pharmacia & Upjohn Co., NY, NY) were given 3 h apart, and 
this regimen was repeated seven days later. At this time two progesterone-containing controlled internal 
drug-releasing devices (CIDRs; Eazi-Breed, Pharmacia & Upjohn, New York, NY) were inserted 
intravaginally to produce luteal phase levels of progesterone. Seven days later PGF2α was again injected 
and CIDRs were removed. Experiments were begun 18 h later, during the early follicular phase. All 
procedures were approved by the West Virginia University Animal Care and Use Committee and 
conducted in accordance with NIH guidelines on the care and use of animals in research. 
Surgeries 
All surgeries were performed under sterile conditions using isofluorane anesthesia. In ewes in both 
Exps. 1 and 2, bilateral chronic 18-gauge guide cannulae were stereotaxically inserted into either the RCh 
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or POA as previously described (19). In ewes in Exp. 1, a chronic 16-gauge cannula was also inserted into 
the lateral ventricle and secured in place, to be used for infusion of an antagonist. Ewes were treated with 
dexamethasone and penicillin pre- and post-operatively, and with daily analgesic (Banamine, Phoenix 
Pharmaceutical, St. Joseph, MO; 125 mg/sheep) starting at the time of anesthesia induction and for 5 days 
after surgery. 
Experimental Approach  
Experiment 1: Will a Kiss1r-antagonist block the senktide-induced increase in LH secretion? 
 Part 1: To determine if the Kiss1r antagonist (p234-penetratin; EZ Biolab Inc., Carmel, IN) was 
able to inhibit LH pulse frequency, two ewes underwent OVX and neurosurgery for insertion of a cannula 
into the lateral ventricle. Following a recovery period of one week saline (120 μL/hr) or the Kiss1r 
antagonist (300 ug/hr) was infused ICV for 2 h and frequent blood samples collected via jugular catheter 
(every 12 min) for 7 h, starting 2 h before the infusion. One week later, the experiment was repeated with 
a crossover of ICV treatment, so that each ewe received each treatment once. The vial of Kiss1r 
antagonist (p235-pentetratin) was reconstituted in sterile physiological saline upon arrival and small 
aliquots were frozen and stored (-20ᵒF) until the day of the experiment.  
 Part 2: To determine whether the senktide-induced increase in LH secretion is kisspeptin-
dependent, a Kiss1r-antagonist was infused icv during RCh senktide treatment. Intact anestrous ewes (n= 
8) with bilateral guide cannulae aimed at the RCh and a lateral ventricle cannula were used. The Kiss1r 
antagonist (300μg/h) or saline (120 μL/h) was infused into the lateral ventricle for one hour, at which time 
senktide-containing microimplants were inserted in the guide cannulae and left in place for the duration of 
the experiment. Infusion of p234-penetratin was continued for four more hours. Frequent blood samples 
(every 12 minutes) were collected via jugular catheters during the entire infusion period (5 h). 
Microimplants were removed at the conclusion of blood sampling and, one week later, the experiment 
was repeated in a crossover design so that each ewe received the antagonist infusion once and saline 
infusion once.  
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 Part 3: To determine if the Kiss1r antagonist retained its efficacy following prolonged storage in 
the freezer, the experiment described in Part 1 was repeated in two new OVX ewes, with the difference 
being that blood samples were collected 2 h prior to infusion, 2 h during infusion, and 2 h post-infusion. 
Experiment 2: Does senktide in the RCh or POA activate ARC kisspeptin neurons? 
We previously demonstrated that the NK3R agonist senktide (obtained from Tocris Bioscience, 
Ellisville, MO) given in the RCh of intact anestrous ewes or POA of ewes during the early follicular 
phase stimulated surge-like LH secretion (see Chapter 3). Therefore, we used tissue sections from ewes in 
those previous studies and assessed activation of kisspeptin neurons, using cFos as an index of activation. 
Dual immunocytochemistry for kisspeptin and cFos (see below) was completed in tissues containing the 
ARC or POA (three sections/area/ewe) in order to examine both kisspeptin populations. The tissues were 
from ewes which received bilateral microimplants (constructed from 22-gauge stainless steel tubing and 
cut to extend 1.5 mm beyond the tip of the guide cannulae) that were empty or contained senktide in 
either the RCh (n=5 and n=7, respectively) or POA (n=5 and n=6, respectively); ewes were killed and 
tissue collected (see below) 3 hours after insertion of microimplants.  
Tissue Collection 
Ewes were euthanized via an overdose of sodium pentobarbital (8-12 ml of Euthasol; 390 mg 
pentobarbital sodium/mL; Webster Veterinary, Devens MA). Two iv injections of heparin (25,000 U) 
were given 10 minutes prior to, and immediately before, pentobarbital. The head was quickly removed 
and perfused via the carotid arteries with 6 liters of 4% paraformaldehyde in 0.1 M phosphate buffer 
containing 0.1% NaNO3. After perfusion, a block of tissue containing the POA and hypothalamus was 
dissected from the brain and stored in paraformaldehyde overnight at 4 C. The tissue was then infiltrated 
with 30% sucrose, and coronal sections (50 μm thick) were cut on a freezing microtome and stored at -20 
C in cryoprotectant. A series of every fifth section was mounted on slides and stained with cresyl violet to 





Dual immunocytochemistry for kisspeptin and cFos was carried out on free-floating sections at room 
temperature as previously described (18). Fos-ir nuclei were detected using an overnight incubation with 
a rabbit polyclonal antibody against c-Fos (1:2500; sc-253, Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA), followed by incubation with biotinylated goat anti-rabbit IgG (1:500; Jackson ImmunoResearch 
Laboratories, Inc.) for 1 h and avidin-biotin-horseradish peroxidase complex (ABC-elite; 1:500; Vector 
Laboratories, Burlingame, CA) for 1 h. Labeling was visualized using nickel-enhanced diaminobenzidine 
(DAB; Sigma) as the chromagen, which produces a black/purple reaction product that is limited to the 
nucleus. Next, the detection of kisspeptin was completed using a polyclonal rabbit antikisspeptin antibody 
(overnight at 1:50,000; no. 564, gift from A. Caraty, Universite Tours, Nouzilly, France), which has been 
previously validated for use in sheep (18;20). Sections were then incubated with biotinylated goat 
antirabbit IgG and followed by ABC-elite as described above. Kisspeptin was visualized using DAB as 
the chromagen, which produces a brown reaction product within the cytoplasm. Sections were mounted 
on Superfrost slides, air-dried, dehydrated, and cover-slipped using Depex (DPX; Electron Microscopy 
Sciences, Hatfield, PA).  
For each tissue section, the numbers of single kisspeptin and dual-labled kisspeptin/Fos cells were 
counted under bright-field illumination in the same manner as previously described (18). A cell was 
considered dual labeled when a black Fos-positive nucleus was observed to be surrounded by brown 
kisspeptin-positive cytoplasm in the same plane of focus. Percentage of dual labeling was calculated as 
the total number of dual-labeled cells divided by the total number of kisspeptin-positive cells.  
Assays 
LH was measured in duplicate using 100-200 μl of plasma in an RIA which has previously been 
validated in sheep (21), and expressed in terms of NIH-LH-S12. The minimal detectable concentration of 
LH in these assays averaged 0.10 ng/tube; intra- and interassay coefficients of variation were 11.8 and 
9.1%, respectively. To confirm stage of the estrous cycle in ovary intact ewes, circulating progesterone 
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was measured in duplicate aliquots of 150 μl plasma using a commercially available solid-phase RIA kit 
(Coat-A-Count Kit, Diagnostics Products Corporation, Los Angeles, CA), which has been validated for 
use in sheep (22). Progesterone concentrations were < 0.3 ng/ml in all follicular phase ewes.  
 
Statistical Analysis 
 In experiment 1, all twelve ewes in the RCh group and 10 of 11 ewes in the POA group had 
proper placement of guide cannulae. In experiment 2, seven of eight ewes had proper placement of guide 
cannulae. Only ewes with proper guide cannulae placement were considered in the statistical analyses.  
  The mean number of single-labeled kisspeptin and dual-labeled kisspeptin/Fos cells in each area 
(POA and ARC) were counted for each animal, and the percentage of kisspeptin cells containing Fos was 
calculated. The mean and SEM were calculated for each group and t tests were used to compare treatment 
groups. In experiment 2, statistically significant differences in mean LH concentrations among treatments 




Experiment 1: Will a Kiss1r-antagonist block the senktide-induced increase in LH secretion? 
 Part 1: LH pulse frequency was inhibited during Kiss1r antagonist infusion in each ewe (Fig. 1). 
Frequency returned to baseline following conclusion of the infusion in both ewes. 
 Part 2: Mean LH concentrations prior to senktide treatment were similar between the saline- and 
Kiss1r antagonist-infused groups (2.3 ± 0.4 vs. 2.5 ± 0.3 ng/mL, respectively). LH concentrations 
significantly increased (P < 0.05) following senktide treatment compared to pre-treatment concentrations 
(P < 0.05) in the saline-infused group, but not the antagonist-infused group. However, there was not a 
significant difference in mean LH concentrations between the saline- and antagonist-infused groups 
during senktide treatment (5.8 ± 1.0 vs. 8.0 ± 3.4 ng/mL, respectively; P > 0.05). The reason for the lack 
of differences in the mean LH concentrations between groups is apparent when profiles from individual 
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ewes are examined. Two ewes exhibited a large surge-like increase in LH secretion following senktide 
during icv saline infusion, but the LH response to senktide during icv infusion of the antagonist was 
suppressed (Fig. 2B). Conversely, two other ewes exhibited a large LH response to senktide only during 
infusion of the Kiss1r antagonist, but not during saline infusion (Fig. 2C). The final three ewes failed to 
respond to senktide treatment in the presence of icv infusion of Kiss1r antagonist or saline (Fig. 2A).  
 Part 3: LH pulse frequency was the same as baseline frequency during infusion of the Kiss1r 
antagonist in one ewe (Fig. 3A) but was lower during infusion of the antagonist in the other ewe (Fig. 
3B).  
Experiment 2: Does senktide in the RCh or POA activate ARC kisspeptin neurons? 
 In the RCh group, average LH concentrations peaked at 16.9 ± 3.4 ng/mL (Chapter 3, Exp. 2). In 
these ewes, the number of cells expressing kisspeptin was not significantly altered by treatment in either 
the ARC or the POA (data not shown). However, fewer kisspeptin neurons were observed within the 
POA compared to the ARC, consistent with what has previously been reported (11;18). Senktide 
treatment in the RCh significantly increased the percent colocalization of ARC kisspeptin/Fos compared 
to empty implants (62.6 ± 5.3% vs. 9.7 ± 2.9%; ; Fig. 4A). LH concentration was significantly higher in 
the senktide treated group compared to the control group at the time of perfusion (Fig. 4C). Senktide 
treatment in the RCh did not alter POA kisspeptin expression of Fos.  
 Following senktide treatment in the POA, average peak LH concentration was 22.4 ± 9.1 ng/mL 
(Chapter 3, Exp. 3). No differences in the number of cells expressing kisspeptin were observed between 
treatment groups (data not shown). The percentage of ARC kisspeptin cells expressing Fos was 
significantly higher in the senktide-treated ewes compared to those receiving empty implants (40.6 ± 
6.9% vs. 19.1 ± 5.9%; p < 0.05; Fig. 4B).  LH concentration was significantly higher in the senktide 
treated group compared to the control group at the time of perfusion (Fig. 4D). Senktide in the POA did 






 To assess whether senktide acts in the RCh to stimulate LH secretion via kisspeptin, we attempted 
to block Kiss1r while treating with senktide in the RCh to see if senktide would still elicit LH secretion. 
Unfortunately we observed inconsistent results in this experiment. Consistent with the hypothesis that 
NK3R activation in the RCh acts through kisspeptin to cause LH secretion, we observed that the Kiss1r 
antagonist appeared to block the senktide-induced increase in LH secretion in two ewes. However, in two 
other ewes, we observed a response to senktide only during the Kiss1r antagonist infusion and not during 
saline infusion. In the three remaining ewes, senktide did not alter LH secretion during either the Kiss1r 
antagonist or saline infusion periods.  
 One possible reason for the discrepancy in these results is that the antagonist may have lost its 
efficacy prior to the final blood collection. Although the same lot and shipment of p234-pen was used for 
all experiments, and the antagonist was tested and confirmed to inhibit LH pulse frequency in OVX ewes 
(Figure 2) prior to use in this experiment, we suspect that the increased length of time stored in the freezer 
until the final experimental day may have led to decreased potency of the drug. We have previously 
observed a decrease in potency of other Kiss1r antagonists in our laboratory following prolonged storage, 
albeit on that occasion the length of time in storage was more prolonged. Therefore we tested the 
remainder of that lot of antagonist in two new OVX ewes and found that some of the efficacy had been 
lost (Figure 4). However, at least one of the ewes who received the Kiss1r antagonist during the second 
part of the crossover experiment exhibited a blunted response to senktide during the antagonist infusion, 
indicating that, at least in this animal, the antagonist retained its potency. We have further analyzed the 
data for effect of treatment order on efficacy of senktide treatment as well as placement of guide cannulae 
within the RCh, but none of these parameters can explain the inconsistency in our results. One important 
aspect to also point out is that only 2 of 8 ewes exhibited a surge-like LH response to senktide during 
saline infusion. In previous experiments from our laboratory, senktide typically produces a very 
consistent LH response when placed in the RCh. Thus we conclude that there was likely an additional 
confounding factor or factors which contributed to the inconsistency in the results from this experiment. 
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Two possible causes for the lack of effect of senktide in this experiment are:   1) the stress of saline 
infusion into the lateral ventricle may have inhibited LH secretion or 2) this experiment was done late in 
the anestrus season so that the seasonal decrease in NK3R expression in the RCh may have already begun 
(8). Therefore, while we believe that this experiment was well-designed, further experiments will be 
needed to obtain conclusive results. It is expected that such experiments will be completed during the next 
anestrus season.  
 Using Fos as an index of neuronal activation, we found that senktide treatment in either the RCh 
or the POA increases activation of KNDy neurons in conjunction with an increase in LH secretion, 
indicating that NK3R activation in the RCh or POA likely stimulates GnRH/LH secretion via ARC 
kisspeptin neurons. Kisspeptin has been suggested to mediate the effects of NKB across various species 
since NK3R are expressed in KNDy neurons in rats (23), mice (24), and sheep (17). One group found 
NK3R coexpressed by 16% of GnRH neurons in rats (23), however, no evidence for NK3R expression in 
GnRH neurons has been found in ewes (17). Additionally, blocking kisspeptin signaling has been shown 
to abolish the senktide-induced stimulation of LH secretion in monkeys (25), and a similar result is 
observed in GPR54 knockout mice, which failed to respond to senktide (26). All of these aforementioned 
workers proposed that senktide acts directly on KNDy neurons. In contrast, our data indicates that 
senktide can act in the RCh or POA to stimulate KNDy neurons indirectly. Our Fos data confirms that 
senktide acts at least in part via ARC kisspeptin neurons.  
 Although senktide treatment in the POA increased activation of KNDy neurons in conjunction 
with increased LH secretion, the increase from baseline kisspeptin/Fos colocalization was lower than that 
seen in KNDy neurons following RCh senktide treatment (5.5-fold increase compared to a 14-fold 
increase, respectively). This difference in activation fits with the difference in magnitude of the LH 
increase following senktide in the RCh compared to the POA in previous work. Senktide microimplants 
in the RCh in follicular phase ewes stimulated surge-like LH secretion with a peak of approximately 30 
ng/mL (8), while the average peak value we observed in our POA experimental group was 22 ng/mL 
(Chapter 3). The apparent larger response in the RCh may be due to the fact that the NK3R are expressed 
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in a smaller area in the RCh compared to the pattern of expression in the POA, where NK3R are more 
widely scattered (17). In agreement with this, we have previously shown that an NK3R antagonist 
(SB222200) given in the POA does not alter an E2-induced LH surge (see Chapter 3), likely due to the 
low solubility of SB222200, making it difficult for the antagonist to reach the scattered NK3R-containing 
cells. However, senktide, which is highly soluble in aqueous solutions, is able to diffuse more fully and, 
therefore, it can interact with sufficient NK3R to stimulate the surge-like LH secretion, albeit to different 
degrees in different areas. While the identity of the NK3R-expressing neurons in POA is unknown, the 
lack of activation of POA kisspeptin neurons following POA senktide treatment indicates that the NK3R-
positive neurons are probably not kisspeptin neurons.  
 With senktide treatment in either the RCh or POA, there was no change observed in Fos 
expression in the POA kisspeptin neurons, which suggests that NK3R activation in these areas does not 
act via POA kisspeptin neurons. In contrast, during a typical preovulatory surge in ewes there is an 
increase in activation of both ARC and POA kisspeptin neurons (18). Therefore, lack of POA kisspeptin 
activation following senktide treatment suggests that either senktide is not inducing an LH surge or that 
senktide is only inducing a partial surge. The latter idea is supported by the fact that peak LH 
concentrations following senktide are approximately 22- 32 ng/mL, which is much lower than typical LH 
concentrations during an endogenous LH surge (~100 ng/mL), as well as by our finding that the NK3R 
antagonist (SB222200) decreased the surge amplitude by only 40% (Chapter 3). The pathway through 
which POA kisspeptin neurons are activated during the preovulatory surge is unknown. Since POA 
kisspeptin neurons do not express Kiss1r (11), it is unlikely that KNDy neurons are involved in their 
activation, which fits with the data herein.  
 Another piece of this puzzle which needs to be completed is to determine how NK3R-positive 
neurons in the RCh or POA interact with ARC kisspeptin neurons. Together with our collaborators, Dr. 
Michael Lehman and Dr. Lique Coolen, we are in the process of assessing projections from the RCh to 
the ARC via injection of an anterograde tract tracing agent into the RCh.  Based on preliminary data (27), 
there appears to be direct projections from the RCh to KNDy neurons in the ARC, a finding which fits 
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nicely with the increased activation of KNDy neurons presented herein.  The identity of the RCh neurons 
that project to KNDy neurons and whether these neurons are the same population that express NK3R 
remains unknown. However, they are not the much studied A15 dopamine neurons (8) which are 
localized to the RCh of ewes and which play an important role in seasonal breeding (28;29). Further 
studies are needed to better characterize this pathway. Possible anatomical pathways connecting neurons 
in the POA with KNDy neurons have not yet been examined, although we plan to do this in future 
experiments. 
 In summary, our data herein show that activation of NK3R by senktide in either the RCh or POA 
results in stimulation of KNDy neurons and the concomitant surge-like LH secretion. However, this 
response does not seem to involve POA kisspeptin neurons. Confirmation that senktide acts only via 
kisspeptin neurons will need further experimentation since our attempt to block the effects of senktide in 
the RCh on LH release with a Kiss1r antagonist yielded mixed results. Hopefully, additional work will 
allow us to determine if NK3R activation in RCh elicits the robust increase in LH secretion exclusively 
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Figure 1. LH profiles from OVX ewes (n=2) given icv infusion of the Kiss1r antagonist (p234-pen) or 
saline, in a crossover experiment, to determine if the Kiss1r antagonist suppresses LH pulse frequency. 
Solid circles depict peaks of LH pulses. White bars depict saline treatment and black bars depict Kiss1r 

































































































Figure 2.  Representative LH profiles from ewes given icv infusion of the Kiss1r antagonist (p234-pen, 
solid circles) or saline (open circles) during RCh treatment with senktide microimplants. LH responses to 




























































Figure 3  
 
         
 
        
 
 
Figure 3.  LH profiles from OVX ewes (n=2) given icv infusion of the Kiss1r antagonist (p234-pen) as a 
follow-up to the Kiss1r antagonist/senktide microimplant experiment (Exp. 2, part 2) to assess efficacy of 











































































                        
Figure 4.  Kisspeptin cells in the ARC exhibit increased activation following senktide treatment. Mean 
percent colocalization with Fos is increased in ARC kisspeptin neurons, but not POA kisspeptin neurons, 
by senktide treatment in either the RCh (A) or the POA (B), in conjunction with an significant increase in 














































































































THE ROLE OF NKB IN LH PULSE GENERATION 
 Research findings to date on the role of kisspeptin and NKB largely agree that KNDy neurons 
play a key role in pulse generation in a variety of species. Based on the current model (Ch. 1, Fig. 1), 
NKB is thought to be responsible for initiation of each pulse, DYN acts to terminate the pulse, and 
kisspeptin serves as a stimulatory output to GnRH neurons. In line with this proposed role in the control 
of GnRH pulses, these neurons also appear to mediate the negative feedback actions of E2 on tonic LH 
secretion in rodents and sheep. My findings herein agree with these roles for ARC kisspeptin and NKB 
neurons in ewes. First, we confirmed that kisspeptin neurons in the ARC, but not in the POA, exhibit 
increased activation in the short- or long-term absence of E2, indicating that the activity of KNDy neurons 
is  typically under E2 negative feedback regulation and that activation of  these ARC  neurons is 
associated with the increase in pulsatile LH release observed following ovariectomy. Second, 
administration of the NK3R agonist, senktide, within the ARC stimulated LH secretion compared to 
control ewes.  However, the amplitude of this increase in LH was lower that observed when senktide was 
given in the POA or RCh. The profile we observed following senktide treatment in the ARC revealed an 
increase in baseline values making it difficult to properly assess pulse frequency. Because NKB 
stimulates LH pulse frequency in OVX ewes (1), it is likely that ARC senktide treatment increased LH 
pulse frequency to a point that we could not observe a return to baseline between pulses.  
 In contrast to senktide, treatment with NKB in the ARC of follicular phase ewes did not 
significantly alter LH secretion. There are at least a few possible explanations for this difference in 
actions of these NK3R agonists. As mentioned in Ch. 3, one obvious explanation lies in the difference in 
the solubility of the two agonists, i.e. senktide is highly soluble in aqueous solutions while NKB is of low 
solubility.  Thus, senktide may diffuse further from the implant site and reach a much larger number of 
NK3R-positive neurons than NKB.  Also, senktide is highly specific for NK3R while NKB may act via 
multiple NKB receptors, as has been recently confirmed in mice (2). This is important in that interactions 
with multiple NKB receptor subtypes may alter the overall outcome of NKB administration if activation 
of either the NK1R or NK2R receptor subtype results in inhibition of GnRH secretion. Therefore, NKB 
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would not stimulate a large increase in LH secretion as was observed with senktide treatment, which only 
acts through a “stimulatory” NK3R. There is some evidence that activation of NK2R or NK1R, by 
neuropeptide K (NPK) or substance P, respectively, can inhibit LH secretion in female rats (3;4). 
Stimulatory effects of these agonists have also been observed in rats (5) and in mice (2). However, these 
substances and their actions have not been investigated in ewes, and the location and distribution of 
NK1R and NK2R in the ovine hypothalamus is unknown. Finally, as noted above, ARC NKB 
microimplants stimulated LH pulse frequency in OVX ewes (6), an effect not seen in the follicular phase; 
one simple explanation for this discrepancy is that LH pulse frequency is considerably faster in the 
follicular phase, than in OVX, ewes (7) so further stimulation is not possible because it may already be 
close to maximal.  
 In summary, data gained in this portion of my dissertation, which focused on tonic LH secretion 
and E2 negative feedback, fit with the current model for the role of KNDy neurons, and specifically NKB, 
in LH pulse generation. However, the specific interactions of NKB or senktide with NKB receptor 
subtypes remain unclear. Further studies are warranted to assess 1) the location of NK1R and NK2R 
within the sheep hypothalamus and 2) whether activation of non-NK3 receptor subtypes yield inhibitory 
effects on LH secretion. Furthermore, in order to better assess whether senktide acts in the ARC to 
increase GnRH pulse frequency or GnRH secretion between pulses, the release of GnRH in response to 
ARC senktide should be analyzed.  
 Senktide treatment in the ARC produced a moderate increase in LH secretion, in which LH 
concentrations increased shortly after treatment and were maintained at around that same level for the 
remainder of the sampling period. During this time nadirs did not return to the pre-treatment baseline. We 
speculate that this may be indicative of increased pulse frequency, during which there is not sufficient 
time for LH concentrations to return to baseline between pulses due to the half-life of LH.  Since GnRH 
has a shorter half-life than LH, GnRH pulse nadir may not be altered, allowing us to get a clearer view of 




THE ROLE OF NKB IN THE LH SURGE 
 One current model for the LH surge in ewes proposes a key role for the POA since kisspeptin 
neurons in that area show increased levels of activation during an E2-induced LH surge in ewes (8). 
However, earlier work indicates that E2-containing microimplants placed in the ovine MBH, were 
sufficient to stimulate an LH surge, whereas E2 implants in the POA did not elicit a surge (9). Together, 
these data indicate that the initiation of the LH surge by E2 likely occurs in the MBH but that the POA 
kisspeptin neurons are also involved in the large increase in GnRH secretion. We have shown herein that 
both POA and ARC kisspeptin neurons exhibit increased activation (using Fos as an index; see Ch. 2) 
during an E2-induced LH surge, indicating that kisspeptin neurons in both areas are involved in the surge. 
These findings are in contrast to the finding by Hoffman et al (8) in which they saw no increase in activity 
in ARC kisspeptin neurons during the surge. One possible explanation for this discrepancy is that the 
ewes used in that study had chronic guide tubes traversing the ARC, aimed at the median eminence to 
measure GnRH, which may have disrupted the ARC kisspeptin network. Another possible difference is 
the use of different antibodies, which may have different sensitivities, for detection of Fos in these two 
studies. Despite this discrepancy, the results of two studies monitoring kisspeptin mRNA levels in ewes 
are consistent with our finding that both ARC and POA kisspeptin neurons are active during E2 positive 
feedback in ewes (10;11). 
 Since most NKB neurons in ewes are located within the ARC (12;13) and the vast majority of 
ARC NKB neurons coexpress kisspeptin (14) and are thus activated during the LH surge (Ch. 2), we 
hypothesized that NKB may also be involved in the LH surge. Furthermore, a previous study from our 
laboratory had shown that the NK3R agonist senktide stimulates LH secretion in a pattern resembling a 
surge (15). Studies herein have determined that senktide administered in either the RCh or the POA, but 
not the ARC, elicits surge-like LH secretion (Ch. 3), indicating that NK3R activation in these areas might 
be part of the LH surge mechanism. However, at this time, we cannot be certain that the secretion of LH 
in response to senktide actually represents true surge secretion. Senktide administration may be 
stimulating pulse frequency in such a way that pulses occur so close together that we no longer can 
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discern individual pulses. Again, one way to examine this possibility would be to assess GnRH secretion 
following senktide treatment in the RCh and POA.  
 To more definitively determine whether NK3R in the RCh or POA were involved in the GnRH 
surge, we assessed the effect of blocking endogenous NKB action on NK3R in the RCh or POA during an 
E2-induced LH surge. In Ch. 3 we showed that the NK3R antagonist SB222200 in the RCh decreased the 
amplitude of the E2-induced LH surge by 42% on average while placement of the antagonist in the POA 
had no effect. Therefore we propose that only RCh NK3R activation is essential for the full preovulatory 
surge. Furthermore, we suggest that while the NKB-NK3R interaction helps drive LH secretion during the 
surge, it is likely not responsible for LH surge generation since the NK3R antagonist did not alter timing 
of the LH surge. This fits well with the finding that E2 implants in the MBH elicit an LH surge in ewes, 
while E2 treatment in the rostral hypothalamus does not (9), indicating that E2 in the MBH is likely 
responsible for surge initiation.  
 We acknowledge that based on these data, we cannot rule out the possibility that the NK3R-NKB 
interaction in the POA is important for full expression of the GnRH surge.  Solubility of SB222200 in 
aqueous solutions is very low and NK3R in the POA are more widely scattered than those in the RCh 
(16).  Thus, SB222200 treatment in the POA may not reach sufficient numbers of NK3R receptor-
expressing neurons in this area to alter the surge.  Therefore, the role of POA NK3R activation in the LH 
surge will require further investigation.  
 After determining that activation of NK3R-positive neurons in the RCh is essential to achieving 
the full LH surge, we next examined one possible pathway through which this activation alters LH 
secretion, namely via kisspeptin-containing neurons. It was previously shown that blocking Kiss1r (via 
icv infusion of a Kiss1r antagonist) decreases LH surge amplitude by ~50% in ewes (17). Since 
SB222200 microimplants in the RCh produced a decrease of similar magnitude, and other data suggests 
that the stimulatory action of NKB or senktide in the ARC on tonic LH secretion is mediated by 
kisspeptin signaling, we hypothesized that NK3R-positive neurons in the RCh act via kisspeptin to alter 
LH secretion. Herein we have shown that senktide treatment in the RCh increased kisspeptin/Fos 
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colocalization in the ARC, but not in the POA, which is coincident with the surge-like secretion of LH. 
Together with the ICC data, these findings indicate that LH secretion induced by RCh NK3R activation 
may be kisspeptin-dependent, and it appears to be ARC, not POA, kisspeptin that is involved, based on 
our ICC data. In order to further test the possible involvement of the POA or ARC kisspeptin population 
in the senktide-induced LH response, we could potentially ‘knockdown’ one population at a time, for 
example using an anti-kisspeptin lenti-viral vector injected directly into the area of interest, prior to 
senktide experiments. This would determine whether either population of kisspeptin neurons is necessary 
for the senktide effects on LH secretion.  
 Finally, in collaboration with colleagues, we are completing tract tracing experiments to assess 
projections from the RCh in ewes. Preliminary findings indicate that RCh neurons project to KNDy 
neurons, revealing an anatomical pathway through which these interactions may directly occur (18). 
However, we do not yet know if these RCh neurons are NK3R-positive. One way to determine this is by 
injecting a retrograde tract tracer into the ARC, and using dual ICC to determine if RCh neurons 
expressing the tract tracer also express NK3R.  
 In summary, the data obtained during my dissertation work warrant a modification to the existing 
model that kisspeptin alone is critical for GnRH surge generation in ewes. We postulate that a group of 
NK3R-positive neurons in the RCh receive input from NKB neurons originating in the ARC during the 
pre-surge phase. Once activated, the NK3R neurons can directly stimulate KNDy neurons to enhance LH 
surge amplitude (Fig. 1).  Preliminary data indicates that NK3R-positive neurons in the RCh exhibit 
increased activation during the LH surge (unpublished data; Christina Merkley and Mike Lehman), 




































Figure 1: Newly proposed model of the GnRH/LH surge in ewes, showing the relationship of 
NK3R-positive RCh neurons (grey) to ARC KNDy neurons (green and purple).  
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  Of course, some unresolved questions remain. First, how do KNDy neurons in the ARC mediate 
both tonic and surge secretion of GnRH/LH? One aspect of this idea that must be reconciled is how the 
same population of neurons can mediate both negative and positive E2 feedback. Two possible 
explanations have been proposed: 1) two different subsets of KNDy neurons mediate the different actions 
of E2 or 2) the same set of neurons responds differently to high or low concentrations of E2, perhaps 
resulting in the initiation of different intracellular signaling mechanisms (19;20). Our data in Ch. 2 
supports the latter explanation since ~90% of KNDy neurons were activated following OVX and ~50% 
were activated at the time of surge.  
  NKB may play a role in this differential regulation of LH secretion. For example, does NKB 
activate neurons in the RCh only during the surge? It is possible that NKB only reaches the RCh in 
significant concentrations during the surge or, in contrast, that NKB reaches the RCh at times other than 
during the LH surge, but that NK3R availability in the RCh is only high enough to respond during the late 
follicular phase. In order to assess the possible change in receptor availability, one could look at NK3R 
expression and/or receptor internalization in the RCh during surge versus non-surge time points.  
 Furthermore, it is possible that output from the NK3R-positive cells in the RCh is reduced during 
non-surge times such that the NKB signal reaches the RCh NK3R, but output from those neurons is 
inhibited. Since the identity of the RCh neurons that project to KNDy neurons remains unknown, a first 
step in testing this hypothesis would be to determine the neuronal phenotype(s) of NK3R cells in this 
area.  
 Another way to determine if the LH secretion in response to senktide is part of the mechanism 
driving the surge is to complete the same type of experiments in male counterparts (E2-treated wethers), 
because the GnRH/LH surge is sexually differentiated in sheep, with males or androgen-treated females 
not exhibiting surges (18;21). Therefore, if you administer senktide to males and see the same surge-like 
LH profile, it would indicate that it is actually not a surge but rather high frequency LH secretion, as 
mentioned above. On the other hand, if the males do not exhibit a similar LH secretion profile in response 
to senktide, it would indicate that senktide stimulates a true LH surge in females.  
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 Dynorphin is the third neuropeptide of the KNDy moniker. Thus, a possible role for DYN must 
also be considered for the surge-related actions of NKB.  DYN is clearly involved in mediating the 
inhibitory effects of progesterone on GnRH secretion. If DYN release or interaction with its receptors is 
decreased during the surge (thus turning off a “brake” on LH secretion), this could allow NKB levels to 
reach a threshold for activation of RCh NK3R-positive neurons. However, it has previously been shown 
that μ-receptors, but not κ-receptors, are potentially involved in inhibition of the LH surge (22-26), and 
furthermore, EOP antagonists do not advance the surge in ewes (22;23;27). Therefore it is unlikely that 
DYN is involved in surge regulation. 
 The data herein has revealed a previously unknown portion of the GnRH/LH surge mechanism in 
ewes involving NK3R-positive neurons located in the RCh. However, many of the pathways responsible 
for the stimulatory actions of NK3R activation in this area on GnRH release remain to be determined.  
Hopefully, the identification of these mechanisms will become the focus of many studies to follow in the 
future.  
















 1.  Goodman RL, Hileman SM, Nestor CC, Porter KL, Connors JM, Hardy SL, Millar RP, 
Cernea M, Coolen LM, Lehman MN 2013 Kisspeptin, neurokinin B, and dynorphin act in the 
arcuate nucleus to control activity of the GnRH pulse generator in ewes. Endocrinology 
 2.  de Croft S, Boehm U, Herbison AE 2013 Neurokinin B activates arcuate kisspeptin neurons 
through multiple tachykinin receptors in the male mouse. Endocrinology 
 3.  Duval P, Lenoir V, Kerdelhue B 1998 The in vitro effect of substance P on the GnRH-induced 
LH release depends on the steroidal environment and is reverted by a NK1 receptor antagonist (RP 
67580) in the cycling female rat. Neuropeptides 32:97-101 
 4.  Sahu A, Kalra SP 1992 Effects of tachykinins on luteinizing hormone release in female rats: 
potent inhibitory action of neuropeptide K. Endocrinology 130:1571-1577 
 5.  Hatae T, Kawano H, Karpitskiy V, Krause JE, Masuko S 2001 Arginine-vasopressin neurons in 
the rat hypothalamus produce neurokinin B and co-express the tachykinin NK-3 receptor and 
angiotensin II type 1 receptor. Arch Histol Cytol 64:37-44 
 6.  Goodman RL, Hileman SM, Nestor CC, Porter KL, Connors JM, Hardy SL, Millar RP, 
Cernea M, Coolen LM, Lehman MN 2013 Kisspeptin, neurokinin B, and dynorphin act in the 
arcuate nucleus to control activity of the GnRH pulse generator in ewes. Endocrinology 
 7.  Karsch FJ, Foster DL, Bittman EL, Goodman RL 1983 A Role for Estradiol in Enhancing 
Luteinizing-Hormone Pulse Frequency During the Follicular Phase of the Estrous-Cycle of Sheep. 
Endocrinology 113:1333-1339 
 8.  Hoffman GE, Le WW, Franceschini I, Caraty A, Advis JP 2011 Expression of fos and in vivo 
median eminence release of LHRH identifies an active role for preoptic area kisspeptin neurons in 
synchronized surges of LH and LHRH in the ewe. Endocrinology 152:214-222 
 9.  Caraty A, Fabre-Nys C, Delaleu B, Locatelli A, Bruneau G, Karsch FJ, Herbison A 1998 
Evidence that the mediobasal hypothalamus is the primary site of action of estradiol in inducing the 
preovulatory gonadotropin releasing hormone surge in the ewe. Endocrinology 139:1752-1760 
 10.  Estrada KM, Clay CM, Pompolo S, Smith JT, Clarke IJ 2006 Elevated KiSS-1 expression in 
the arcuate nucleus prior to the cyclic preovulatory gonadotrophin-releasing hormone/lutenising 
hormone surge in the ewe suggests a stimulatory role for kisspeptin in oestrogen-positive feedback. 
Journal of Neuroendocrinology 18:806-809 
114 
 
 11.  Smith JT, Li Q, Pereira A, Clarke IJ 2009 Kisspeptin neurons in the ovine arcuate nucleus and 
preoptic area are involved in the preovulatory luteinizing hormone surge. Endocrinology 150:5530-
5538 
 12.  Foradori CD, Amstalden M, Goodman RL, Lehman MN 2006 Colocalisation of dynorphin a 
and neurokinin B immunoreactivity in the arcuate nucleus and median eminence of the sheep. 
Journal of Neuroendocrinology 18:534-541 
 13.  Goubillon ML, Forsdike RA, Robinson JE, Ciofi P, Caraty A, Herbison AE 2000 Identification 
of neurokinin B-expressing neurons as an highly estrogen-receptive, sexually dimorphic cell group 
in the ovine arcuate nucleus. Endocrinology 141:4218-4225 
 14.  Goodman RL, Lehman MN, Smith JT, Coolen LM, de Oliveira CV, Jafarzadehshirazi MR, 
Pereira A, Iqbal J, Caraty A, Ciofi P, Clarke IJ 2007 Kisspeptin neurons in the arcuate nucleus 
of the ewe express both dynorphin A and neurokinin B. Endocrinology 148:5752-5760 
 15.  Billings HJ, Connors JM, Altman SN, Hileman SM, Holaskova I, Lehman MN, McManus CJ, 
Nestor CC, Jacobs BH, Goodman RL 2010 Neurokinin B acts via the neurokinin-3 receptor in 
the retrochiasmatic area to stimulate luteinizing hormone secretion in sheep. Endocrinology 
151:3836-3846 
 16.  Amstalden M, Coolen LM, Hemmerle AM, Billings HJ, Connors JM, Goodman RL, Lehman 
MN 2010 Neurokinin 3 receptor immunoreactivity in the septal region, preoptic area and 
hypothalamus of the female sheep: colocalisation in neurokinin B cells of the arcuate nucleus but 
not in gonadotrophin-releasing hormone neurones. J Neuroendocrinol 22:1-12 
 17.  Smith JT, Li Q, Yap KS, Shahab M, Roseweir AK, Millar RP, Clarke IJ 2011 Kisspeptin is 
essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine 
median eminence. Endocrinology 152:1001-1012 
 18.  Coolen LM, Smith TG, Lehman MN, Hileman SM, Connors JM, Goodman RL, Arcuate 
KNDy neurons receive afferent projections from the retrochiasmatic area in the ewe. (Abstract) 
 19.  Glidewell-Kenney C, Hurley LA, Pfaff L, Weiss J, Levine JE, Jameson JL 2007 Nonclassical 
estrogen receptor alpha signaling mediates negative feedback in the female mouse reproductive 
axis. Proc Natl Acad Sci U S A 104:8173-8177 
 20.  Lehman MN, Coolen LM, Goodman RL 2010 Minireview: Kisspeptin/Neurokinin B/Dynorphin 
(KNDy) Cells of the Arcuate Nucleus: A Central Node in the Control of Gonadotropin-Releasing 
Hormone Secretion. Endocrinology 151:3479-3489 
115 
 
 21.  Foster DL, Padmanabhan V, Wood RI, Robinson JE 2002 Sexual differentiation of the 
neuroendocrine control of gonadotrophin secretion: concepts derived from sheep models. 
Reproduction Supplement 59:83-99 
 22.  Conover CD, Kuljis RO, Rabii J, Advis JP 1993 Beta-endorphin regulation of luteinizing 
hormone-releasing hormone release at the median eminence in ewes: immunocytochemical and 
physiological evidence. Neuroendocrinology 57:1182-1195 
 23.  Currie WD, Joseph IB, Rawlings NC 1991 Morphine, naloxone and the gonadotrophin surge in 
ewes. J Reprod Fertil 92:407-414 
 24.  Domanski E, Chomicka LK, Ostrowska A, Gajewska A, Mateusiak K 1991 Release of 
luteinizing hormone-releasing hormone, beta-endorphin and noradrenaline by the nucleus 
infundibularis/median eminence during periovulatory period in the sheep. Neuroendocrinology 
54:151-158 
 25.  Pillon D, Caraty A, Fabre-Nys C, Bruneau G 2003 Short-term effect of oestradiol on neurokinin 
B mRNA expression in the infundibular nucleus of ewes. J Neuroendocrinol 15:749-753 
 26.  Walsh JP, Clarke IJ 1996 Effects of central administration of highly selective opioid mu-, delta- 
and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-
induced LH surge in ovariectomized ewes. Endocrinology 137:3640-3648 
 27.  Horton RJ, Clarke IJ 1988 Lack of an effect of morphine or naloxone on the oestrogen-induced 













Katrina L. Porter 
West Virginia University      
Department of Physiology and Pharmacology   
P.O. Box 9229       
Morgantown, WV 26506   
H: 304-692-0931 
W: 304-293-1505  
E-mail: ksites@mix.wvu.edu     
 
EDUCATION 
2013  Ph.D. Biomedical Sciences  West Virginia University 
2006  B.S. Exercise Physiology  West Virginia University 
 
Doctoral Advisor: Robert L. Goodman, Ph.D.  
Doctoral Dissertation: The Role of Neurokinin B in the Regulation of the Preovulatory LH     
                                              Surge in Ewes 
RESEARCH EXPERIENCE 
2010-  Research Assistant, Laboratory of Dr. Robert L. Goodman, Ph.D. 
2013  West Virginia University, Department of Physiology and Pharmacology 
  Morgantown, WV 
 Project: Role of Ovine Neurokinin B in the Regulation of the Preovulatory  
                                                                      LH Surge in Ewes        
 Performed immunocytochemistry and immunofluorescence on hypothalamic tissue 
sections to assess neuronal activation (including but not limited to kisspeptin, Fos, 
NKB) 
 Venipuncture for blood collection (ovine) 
 Insertion of jugular catheters (ovine) 
 Neurosurgery: stereotaxic insertion of chronic guide tubes in specific brain areas 
(ARC, POA, PVN, RCh 
 Bilateral ovariectomy surgery  
 Tissue sectioning: hypothalamic tissue blocks using a freezing microtome 
 Microinjections or microinfusions of neuropeptides or receptor agonists or 







2007-  Research Assistant, Laboratory of Dr. Timothy R. Nurkiewicz, Ph.D. 
2010  West Virginia University, Department of Physiology and Pharmacology 
  Morgantown, WV 
  Project: Microvascular effects of pulmonary exposure to diesel-exhaust             
                                                                             particles 
 Conducted intravital microscopy of the spinotrapezius muscle in rats to assess 
microvascular reactivity  
 Performed isolated vessel experiments on skeletal muscle arterioles 
 
PUBLICATIONS 
Goodman RL, SM Hileman, CC Nestor, KL Porter, JM Connors, SL Hardy, RP Millar, M Cernea, 
 LM Coolen, MN Lehman. 2013 Kisspeptin, neurokinin B, and dynorphin act in the arcuate 
 nucleus to control activity of the GnRH pulse generator in ewes. Endocrinology 154(11):4259-69. 
Merkley CM*, KL Porter*, LM Coolen, SM Hileman, HJ Billings, S Drews, RL Goodman, MN  
 Lehman. (*Shared first authorship) 2012 KNDy (Kisspeptin/Neurokinin B/Dynorphin) 
 Neurons are Activated During Both Pulsatile and Surge Secretion of LH in the Ewe. 
 Endocrinology 153(11); 5406-14.  
 
PAPERS IN PREPARATION 
Porter KL, SM Hileman, SL Hardy, CC Nestor, RL Goodman (submitted) Neurokinin-3     
            Receptor Activation in the Retrochiasmatic Area is Essential for the Full Preovulatory LH  
            Surge in Ewes 
 
Porter KL, SM Hileman, RL Goodman (in preparation) Senktide Stimulates LH Secretion via  Arcuate 
 Kisspeptin Neurons in Ewes 
 
ABSTRACTS 
KL Porter, SM Hileman, SL Hardy, RL Goodman. 2013 Neurokinin B signaling in the  retrochiasmatic 
 area is essential for the full preovulatory LH surge in ewes. Annual meeting of the Society 
 for Neuroscience (San Diego, CA) 
SM Hileman, Meadows LJ, Porter KL, Coolen LM, Fergani C, Rempel LA, Cushman RA, Oliver 
 WT, Wright EC, Miles JR, Lents CA.  2013 Effect of progesterone on kisspeptin and 
 neurokinin B cell numbers in the arcuate nucleus of the female pig.  Annual meeting of  the 
 Society for Neuroscience (San Diego, CA) 
RL Goodman, KL Porter, JM Connors, SM Hileman. 2013 Neurokinin B (NKB) and the NKB receptor 
agonist, senktide, act in the ovine arcuate nucleus to produce different patterns of LH release. 
Annual meeting of the Endocrine Society (San Francisco, CA) 
KL Porter, SM Hileman, SL Hardy, RL Goodman. 2013 Senktide administration in the  retrochiasmatic 
 area and preoptic area stimulates surge-like LH secretion in ewes. Annual meeting of the 
 Endocrine Society (San Francisco, CA) 
118 
 
Goodman RL, KL Porter, JM Connors, CC Nestor, MN Lehman, SM Hileman. 2012 Evidence  that 
 dynorphin, but not glutamate or GnRH, acts in the arcuate nucleus of the ewe to control episodic 
 GnRH release. Annual meeting of the Society for Neuroscience (New Orleans, LA) 
Porter, KL, SM Hileman, S Drews, RL Goodman. 2011 Arcuate kisspeptin neurons are rapidly activated 
by removal of estrogen negative feedback in anestrous ewes. Annual meeting for the Society for 
Neuroscience (Washington, DC)  
 
Porter, KL, TR Nurkiewicz. 2010 Diesel exhaust particle exposure augments arteriolar 
mechanotransduction. The Toxicologist 114(1):368, 1730. Annual meeting for the Society of 
Toxicology (Salt Lake City, UT) 
     
Porter, KL, TR Nurkiewicz. 2010 Arteriolar Mechanotransduction is Altered by     
 Diesel  Exhaust Particle Exposure. NIEHS-EPA Symposium on Air Pollution.   
 (Seattle, WA)  
 
Sites, KL, AG Goodwill, JC Frisbee, TR Nurkiewicz. 2009 Diesel exhaust     
 exposure alters microvascular blood flow and wall shear rate. The Toxicologist,   




2013  West Virginia University, PSIO/NBAN 107, Intro. to Human Anatomy &   
  Physiology 
  Guest Lecturer, Cardiovascular and Lymphatic Systems (7 hours) 
 
Oct 2011- Pierpont Community and Technical College, Fairmont, WV 
May 2012 Adjunct Professor, Anatomy and Physiology 
  Taught Anat. & Phys. lectures and laboratories for undergraduate nursing,   
  veterinary technician, and respiratory therapy students; material included   
  all topics as covered by Hole’s Essentials of Anatomy and Physiology    
  textbook (10
th
 edition). Duties included: lecturing, preparing and teaching labs,   
  writing exams/quizzes, scoring exams/quizzes.    
2011-  West Virginia University, Undergraduate and Graduate Physiology Courses 
2013  Tutor 
   
2011  West Virginia University, PSIO 241, Physiology 
  Guest Lecturer, Blood (2 hours) 
 
RESEARCH SUPPORT 
2009-  NIH Cardiovascular and Pulmonary Disease Training Grant     
2010  NHLBI-T32 Pre-Doctoral training grant  
    Principal Investigator: S.J. Mustafa, West Virginia University 
 
